Annual Statements Open main menu

Clearday, Inc. - Annual Report: 2008 (Form 10-K)

e10vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
ANNUAL REPORT
PURSUANT TO SECTIONS 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Mark One)
     
þ   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the fiscal year ended December 31, 2008
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from                      to                     
Commission File Number 0-21074
SUPERCONDUCTOR TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of
incorporation or organization)
  77-0158076
(IRS Employer
Identification No.)
460 Ward Drive, Santa Barbara, California 93111-2310
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (805) 690-4500
Securities registered pursuant to Section 12(b) of the Act:
     
Title of each class   Name of each exchange on which registered
     
Common stock, $0.001 par value   The NASDAQ Stock Market, LLC
Securities registered pursuant to Section 12(g) of the Act:
None
     Indicate by check mark if the registrant is a well known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o or No þ
     Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o or No þ
     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ or No o
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o Accelerated filer o 
Non-accelerated filer o
(Do not check if a smaller reporting company)
Smaller reporting company þ
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o or No þ
     The aggregate market value of the common stock held by non-affiliates was $33.9 million as of June 28, 2008 (the last business day of our most recently completed second fiscal quarter). The closing price of the common stock on that date was $2.35 as reported by the NASDAQ Capital Market. For purposes of this determination, we excluded the shares of common stock held by each officer and director and by each person who was known to us to own 10% or more of the outstanding common stock as of June 28, 2008. The exclusion of shares owned by the aforementioned individuals and entities from this calculation does not constitute an admission by any of such individuals or entities that he or it was or is an affiliate of ours.
     We had 17,869,030 shares of common stock outstanding as of the close of business on March 2, 2009.
DOCUMENTS INCORPORATED BY REFERENCE
     Items 10, 11, 12, 13 and 14 of Part III incorporate information by reference from the definitive proxy statement for the Registrant’s 2009 Annual Meeting of Stockholders.
 
 


 

SUPERCONDUCTOR TECHNOLOGIES INC.
FORM 10-K ANNUAL REPORT
Year Ended December 31, 2008
Unless otherwise noted, the terms “we,” “us,” “our” refer to the combined and ongoing business
operations of Superconductor Technologies Inc. and its subsidiaries
             
        Page
 
           
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS     1  
 
           
WHERE YOU CAN FIND MORE INFORMATION     1  
 
           
           
 
           
  Business     2  
  Risk Factors     6  
  Unresolved Staff Comments     16  
  Properties     16  
  Legal Proceedings     16  
  Submission of Matters to a Vote of Security Holders     16  
 
           
           
 
           
  Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities     16  
  Selected Financial Data     19  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     20  
  Quantitative and Qualitative Disclosures about Market Risk     30  
  Financial Statements and Supplementary Data     30  
  Controls and Procedures     30  
  Other Information     31  
 
           
           
 
           
  Directors, Executive Officers and Corporate Governance     31  
  Executive Compensation     31  
  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters     31  
  Certain Relationships and Related Transactions, and Director Independence     32  
  Principal Accountant Fees and Services     32  
 
           
           
 
           
  Exhibits and Financial Statement Schedules     32  
 EX-4.1
 EX-10.1
 EX-10.2
 EX-10.14
 EX-21
 EX-23.1
 EX-31.1
 EX-31.2
 EX-32.1
 EX-32.2

i


Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
     This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for these forward looking statements. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and the adequacy of our funding. Other statements contained in this Report that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and other comparable terminology.
     We caution investors that any forward-looking statements presented in this Report, or that we may make orally or in writing from time to time, are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on known results and trends at the time they are made, to anticipate future results or trends.
     Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:
    limited cash and a history of losses;
 
    limited number of potential customers;
 
    limited number of suppliers for some of our components;
 
    no significant backlog from quarter to quarter;
 
    our market is characterized by rapidly advancing technology;
 
    fluctuations in product demand from quarter to quarter can be significant;
 
    the impact of competitive filter products, technologies and pricing;
 
    manufacturing capacity constraints and difficulties; and
 
    general economic conditions.
     For further discussion of these and other factors see, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in this Report.
     This Report and all subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances after the date of this Report.

1


Table of Contents

PART I
ITEM 1. BUSINESS
General
     We are a leading company in high temperature superconductor (“HTS”) materials and related technologies. HTS materials have the unique ability to conduct various signals or energy (e.g., electrical current or radio frequency (“RF”) signals) with little or no resistance when cooled to “critical” temperatures. Electric currents that flow through conventional conductors encounter resistance that requires power to overcome and generates heat. HTS materials can substantially improve the performance characteristics of electrical systems, reducing power loss, lowering heat generation and decreasing electrical noise. Circuits designed to remove interference inherent in some RF signals can also be made from HTS materials. Commercial use of HTS materials requires a number of cutting edge technologies, including development of HTS materials, specialized manufacturing expertise to create uniform thin layers of these materials, expert designs of circuits optimized for HTS materials, and technologies to maintain an extremely low temperature environment for HTS applications (although the critical temperatures for HTS are “high” compared with traditional superconductors, they are still extremely cold by other standards).
Our Proprietary Technology
     We are focused on research and development to maintain our technological edge. As of December 31, 2008, we had 29 employees in our research and development division; eight of our employees have Ph.D.s, and 13 others hold advanced degrees in physics, materials science, electrical engineering and other fields. Our development efforts over the last 21 years have yielded an extensive patent portfolio as well as critical trade secrets, unpatented technology and proprietary knowledge. We enter into confidentiality and non-disclosure agreements with our employees, suppliers and consultants to protect our proprietary information. As of December 31, 2008, we held 57 U.S. patents in the following categories:
    7 patents for technologies directed toward producing thin-film materials and structures, which expire between 2010 and 2025. We have developed a proprietary state-of-the-art manufacturing process for producing HTS thin-films of the highest quality.
 
    29 patents for cryogenic and non-microwave circuit designs, which expire between 2010 and 2026. The expertise of our highly qualified team has allowed us to design and fabricate extremely small, high-performance circuits including RF signal filters.
 
    17 patents covering cryogenics, packaging and systems, which expire between 2013 and 2025. Our proprietary and patented cryogenic packaging innovation provides us with a significant competitive advantage in maintaining our HTS materials at their critical temperatures.
 
    4 patents covering other superconducting technologies, which expire between 2013 and 2015.
     As of December 31, 2008, we also had 15 issued foreign patents, 25 U.S. patent applications pending and 44 foreign applications patents pending.
     We are currently focusing our efforts on applications in areas such as:
    Wireless Networks. Our current commercial products help maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Our products increase capacity utilization, lower dropped and blocked calls, extend coverage, and enable higher wireless data throughput — all while reducing capital and operating costs.
 
    Reconfigurable Handset Filters. The trend in the wireless handset industry is to continually reduce size and cost, while adding more features and making the unit more adaptable to different air interfaces and frequencies throughout the world. This drives the need for more complex and reconfigurable transceivers. We believe our

2


Table of Contents

      strong intellectual property and expertise in frequency agile and thin film filters position us well to meet this demand.
 
    Superconducting Power Transmission Lines. We have entered into a collaborative effort and signed a Material Transfer Agreement with the Department of Energy’s Los Alamos National Laboratory (“LANL”) to apply our HTS expertise to LANL’s research initiative to develop HTS coated conductors for power transmission lines. If successfully developed, HTS superconducting cables could replace copper power transmission lines, resulting in higher capacity with less resistive cable losses.
 
    Government Products. As the worldwide leader in developing tunable HTS filter systems for military applications, we continue to be a crucial partner in the U.S. government’s future success. Our high-performance HTS filter systems have been proven to increase the detection range, reduce interference, and in some cases, detect signals that were previously undetectable with conventional technology. Currently, we actively participate in the development of technologies for application in military communications, signals intelligence, and electronic warfare.
     Our development efforts can take a significant number of years to commercialize, and we must overcome significant technical barriers and deal with other significant risks, some of which are set out in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
Our Business Model
     To be successful, we must use our expertise and our technology to generate revenues in various ways, including government contracts, commercial operations, joint ventures and licenses:
     Government Contracts
     We generate significant revenues from government contracts. We typically own the intellectual property developed under these contracts, and grant the Federal government a royalty-free, non-exclusive and nontransferable license to use it. As a result, our government contracts can not only generate a profit for us, but we can also make additional money through exploiting of the resulting technology in our commercial operations as well as government products, or through licenses or joint ventures. Contracts with the U.S. government contain provisions, and are subject to laws and regulations, that give the government rights and remedies not typically found in commercial contracts, including rights that allow the government to:
    terminate existing contracts for convenience, which affords the U.S. government the right to terminate the contract in whole or in part anytime it wants for any reason or no reason, as well as for default;
 
    reduce or modify contracts or subcontracts, if its requirements or budgetary constraints change;
 
    cancel or reduce multi-year contracts and related orders, if funds for contract performance for any subsequent year become unavailable;
 
    adjust reimbursable contract costs and fees on the basis of audits completed by its agencies through exercise of its oversight rights; and
 
    control or prohibit the export of products.
     Compensation in the event of a termination, if any, is limited to compensation for work completed at the time of termination. In the event of termination for convenience, we may receive a certain allowance for profit on the work performed.

3


Table of Contents

     Commercial Applications
     We have chosen to manufacture and sell certain commercial products on our own. To date, our commercial efforts have been focused on the design, manufacture, and sale of high performance infrastructure products for wireless voice and data applications. We have three current product lines, all of which relate to wireless base stations:
    SuperLink, a highly compact and reliable receiver front-end HTS wireless filter system to eliminate out-of-band interference for wireless base stations, combining filters with a proprietary cryogenic cooler and a cooled low-noise amplifier.
 
    AmpLink, a ground-mounted unit for wireless base stations that includes a high-performance amplifier and up to six dual duplexers.
 
    SuperPlex, a high-performance multiplexer that provides extremely low insertion loss and excellent cross-band isolation designed to eliminate the need for additional base station antennas and reduce infrastructure costs.
     We sell most of our current commercial products to a small number of wireless carriers in the United States, including ALLTEL, AT&T, Sprint Nextel, T-Mobile and Verizon Wireless. Verizon Wireless and AT&T each accounted for more than 10% of our commercial revenues in 2008 and 2007. We are seeking to expand our customer base by selling directly to other wireless network operators and manufacturers of base station equipment, including internationally. Demand for wireless communications equipment fluctuates dramatically and unpredictably. The wireless communications infrastructure equipment market is extremely competitive and is characterized by rapid technological change, new product development, product obsolescence, evolving industry standards and price erosion over the life of a product. We face constant pressures to reduce prices. Consequently, we expect the average selling prices of our products will continue decreasing over time. We expect these trends to continue and may cause significant fluctuations in our quarterly and annual revenues. Our commercial operations are subject to a number of significant risks, some of which are set out in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
     Joint Ventures
     From time to time we may pursue joint ventures with other entities to commercialize our technology. In particular, we have agreed to license certain technology for our SuperLink® interference elimination solution for the China market to a joint venture where we own 45 percent of the equity. In the first quarter of 2008, we received orders from the joint venture for our new TD-SCDMA solution to perform lab trial and field trial activities in China. The lab trial was successfully completed in the second quarter of 2008, and the field trial was successfully completed during the fourth quarter of 2008. The commencement of manufacturing and the transfer of our processes to the joint venture will be driven by product demand from the China market. The joint venture’s activities remain subject to successful product marketing efforts in addition to a number of other conditions, including certain critical approvals from the Chinese and United States governments. In particular, we have been in discussions with the United States government concerning the national security implications of our joint venture and investment from Hunchun BaoLi Communication Co. Ltd. (“BAOLI”). There continues to be no assurance that these conditions will be met, or that all required approvals (if obtained) will be obtained on a timely basis. Even if these conditions are met and the approvals received, the results from our joint venture will be subject to a number of significant risks associated with international operations and new ventures, some of which are set forth in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
     Licenses
     From time to time we grant licenses for our technology to other companies. Specifically, we have granted licenses to, among others, (1) Bruker for Nuclear Magnetic Resonance application, (2) General Dynamics for government applications and (3) Star Cryoelectronics for Superconducting Quantum Interference Device applications.

4


Table of Contents

Manufacturing
     Our manufacturing process involves the assembly of numerous individual components and precision tuning by production technicians. We purchase inventory components and manufacture inventory based on sales forecasts. The parts and materials used by us and our contract manufacturers consist primarily of printed circuit boards, specialized subassemblies, fabricated housing, relays and small electric circuit components, such as integrated circuits, semiconductors, resistors and capacitors. We currently manufacture our SuperLink systems at our facilities in Santa Barbara, California. Principal components of our AmpLink and SuperPlex products are produced by foreign manufacturers. Our Santa Barbara facilities currently also house our AmpLink assembly and distribution center.
     A number of components used in our products are available from only one or a limited number of outside suppliers due to unique designs as well as certain quality and performance requirements. We currently purchase substrates for growth of high-temperature superconductor thin-films from a single supplier because of the quality of those substrates. There are additional components that we source from a single vendor due to the present volume. In addition, key components of our conventional products are manufactured by a sole foreign manufacturer. We do not have guaranteed supply arrangements with any of these suppliers, do not maintain an extensive inventory of parts or components and customarily purchase sole or limited source parts and components pursuant to purchase orders. Our reliance on sole or limited source suppliers involves certain risks and uncertainties, many of which are beyond our control, and some of which are set out in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
Marketing and Sales
     Because we have a concentrated customer base, we primarily sell using a direct sales force in the U.S. We use indirect channels to market our products to select customers internationally. We demonstrate our products at trade shows, and participate in industry conferences. We also use advertising campaigns, email campaigns, direct mailings, and submission of technical and application reports to recognized trade journals to advertise our solutions to potential customers. We also advertise our products through our website, brochures, data sheets, application notes, trade journal reports and press releases. Our sales and marketing efforts are complemented by a team of sales applications engineers who manage field trials and initial installations, as well as provide ongoing pre-sales and post-sales support.
Competition
     We face competition in various aspects of our technology and product development. Our products compete on the basis of performance, functionality, reliability, pricing, quality, and compliance with industry standards. Our current and potential competitors include conventional RF filter manufacturers, including Andrew/CommScope, ADC, Powerwave, and RFS and both established and newly emerging companies developing similar or competing HTS technologies. We also compete with companies that design, manufacture and sell antenna-optimizing multiplexers and companies that seek to enhance base station range and selectivity by means other than a superconducting filter, including many original equipment manufacturers such as Ericsson and Nokia. In addition, we currently supply components and license technology to several companies that may eventually decide to manufacture or design their own HTS components, rather than purchasing or licensing our technology. With respect to our HTS materials, we compete with THEVA, among others. In the government sector, we compete with universities, national laboratories and both large and small companies for research and development contracts, and with larger defense contractors, such as Raytheon and Northrop Grumman, for government products.
Research and Development
     Our research and development efforts primarily involve engineering and design related to improving product lines and developing new products and technologies in the same or similar fields using our core technologies. We spent a total of $7.0 million, $6.1 million, and $5.9 million on research and development for 2008, 2007, and 2006, respectively of which $3.4 million, $3.2 million, and $3.5 million, respectively, was for company-funded research and development. Customer-funded research and development, most of which was attributable to work under contracts with the U.S. Government, represented 52%, 48% and 41% of total research and development costs for each of 2008, 2007, and 2006, respectively.

5


Table of Contents

Environmental Issues
     We use certain hazardous materials in our research, development and manufacturing operations. As a result, we are subject to stringent federal, state and local regulations governing the storage, use and disposal of such materials. Current or future laws and regulations could require substantial expenditures for preventative or remedial action, reduction of chemical exposure, waste treatment or disposal. Although we believe that our safety procedures for the handling and disposing of hazardous materials comply with the standards prescribed by state and federal regulations, there is always the risk of accidental contamination or injury from these materials. To date, we have not incurred substantial expenditures for preventive action with respect to hazardous materials or for remedial action with respect to any hazardous materials accident, but the use and disposal of hazardous materials involves the risk that we could incur substantial expenditures for such preventive or remedial actions. If such an accident were to occur, we could be held liable for resulting damages. The liability in the event of an accident or the costs of such remedial actions could exceed our resources or otherwise have a material adverse effect on our financial condition, results of operations or cash flows.
Corporate Information
     Our facilities and executive offices are located at 460 Ward Drive, Santa Barbara, California 93111, and our telephone number is (805) 690-4500. We were incorporated in Delaware on May 11, 1987. Additional information about us is available on our website at www.suptech.com. The information on our web site is not incorporated herein by reference.
Employees
     As of December 31, 2008, we had a total of 105 employees. None of our employees are represented by a labor union, and we believe that our employee relations are good.
Backlog
     Our commercial backlog consists of accepted product purchase orders with scheduled delivery dates during the next twelve months. We had commercial backlog of $272,000 at December 31, 2008, as compared to $352,000 at December 31, 2007.
ITEM 1A.   RISK FACTORS
     The following section includes some of the material factors that may adversely affect our business and operations. This is not an exhaustive list, and additional factors could adversely affect our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This discussion of risk factors includes many forward-looking statements. For cautions about relying on such forward looking statements, please refer to the section entitled “Forward Looking Statements” at the beginning of this Report immediately prior to Item 1.

6


Table of Contents

Risks Related to Our Business
The current global financial crisis may adversely affect our business, operating results and financial condition.
     The United States economy has recently experienced a financial downturn, with some financial and economic analysts predicting that the world economy may be entering into a prolonged economic downturn characterized by high unemployment, limited availability of credit, increased rates of default and bankruptcy and decreased consumer and business spending. These developments could negatively affect our business, operating results and financial condition in a number of ways. For example, current or potential customers may delay or decrease spending with us or may not pay us, or may delay paying us, for previously purchased products. In addition, this downturn has had, and may continue to have, an unprecedented negative impact on the global credit markets. Credit has tightened significantly in the last several months, resulting in financing terms that are less attractive to borrowers, and in many cases, the unavailability of certain types of debt financing. If this crisis continues or worsens, and if we are required to obtain financing in the near term to meet our working capital or other business needs, we may not be able obtain that financing. Further, even if we are able to obtain the financing we need, it may be on terms that are not favorable to us, with increased financing costs and restrictive covenants.
We have a history of losses and may never become profitable.
     In each of our last five years, we have experienced significant net losses and negative cash flows from operations. In 2008, we incurred a net loss of $12.7 million and had negative cash flows from operations of $12.1 million. In 2007, we incurred a net loss of $9.1 million and had negative cash flows from operations of $5.4 million. Our independent registered public accounting firm has included in its audit reports an explanatory paragraph expressing doubt about our ability to continue as a going concern. If we fail to increase our revenues, we may not achieve and maintain profitability and may not meet our expectations or the expectations of financial analysts who report on our stock.
We may need to raise additional capital, and if we are unable to raise capital our ability to implement our current business plan and ultimately our viability as a company could be adversely affected.
     At December 31, 2008 we had $7.6 million in cash. Our cash resources, together with our line of credit, and a planned inventory reduction, may not be sufficient to fund our business through 2009. We believe one of the key factors to our liquidity will be our ability to successfully execute on our plans to increase sales levels in a highly concentrated industry where we experience significant fluctuations in sales from quarter to quarter. Our cash requirements will also depend on numerous other variable factors, including the rate of growth of sales, the timing and levels of products purchased, payment terms and credit limits from manufacturers, and the timing and level of accounts receivable collections. Because of the uncertainty of these many factors, we may need to raise funds in the next six months to meet our working capital needs.
     We cannot assure you that additional financing will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, it might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.
We rely on a small number of customers for the majority of our commercial revenues, and the loss of any one of these customers, or a significant loss, reduction or rescheduling of orders from any of these customers, could have a material adverse effect on our business, results of operations and financial condition.
     We sell most of our products to a small number of wireless carriers. We derived 92% of our commercial product revenues from Verizon Wireless and AT&T in 2008 and 75% of our commercial product revenues from Verizon Wireless and AT&T in 2007. Our future success depends upon the wireless carriers continuing to purchase our products, and fluctuations in demand from such customers could negatively impact our results. Unanticipated demand fluctuations can have a negative impact on our revenues and business and an adverse effect on our results of operations and financial condition.
In addition, our dependence on a small number of major customers exposes us to numerous other risks, including:

7


Table of Contents

    a slowdown or delay in the deployment, upgrading or improvement of wireless networks by any one customer could significantly reduce demand for our products;
 
    reductions in a single customer’s forecasts and demand could result in excess inventories;
 
    each of our customers have significant purchasing leverage over us to require changes in sales terms including pricing, payment terms and product delivery schedules; and
 
    concentration of accounts receivable credit risk, which could have a material adverse effect on our liquidity and financial condition if one of our major customers declared bankruptcy or delayed payment of their receivables.
     Many of our customers also provide minimal lead-time prior to the release of their purchase orders and have non-binding commitments to purchase from us. If we fail to forecast our customer’s demands accurately, we could experience delays in manufacturing, which could result in customer dissatisfaction. Additionally, these factors further impact our ability to forecast future revenue.
We face competition with respect to various aspects of our technology and product development.
     Our products compete on the basis of performance, functionality, reliability, pricing, quality, and compliance with industry standards. Our current and potential competitors include conventional RF filter manufacturers, Andrew/CommScope, ADC, Powerwave, and RFS and both established and newly emerging companies developing similar or competing HTS technologies. We also compete with companies that design, manufacture and sell antenna-optimizing multiplexers and companies that seek to enhance base station range and selectivity by means other than a superconducting filter, including many original equipment manufacturers such as Ericsson and Nokia. In addition, we currently supply components and license technology to several companies that may eventually decide to manufacture or design their own HTS components, rather than purchasing or licensing our technology. With respect to our HTS materials, we compete with THEVA, among others. In the government sector, we compete with universities, national laboratories and both large and small companies for research and development contracts, and with larger defense contractors, such as Raytheon and Northrop Grumman, for government products. If we are unable to compete successfully against our current or future competitors, then our business and results of operations will be adversely affected.
The wireless communication industry is highly concentrated, which limits the number of potential customers, and further industry consolidation could result in the loss of key customers.
     The wireless communication industry is highly concentrated in nature and may become more concentrated due to anticipated industry consolidation. As a result, we believe that the number of potential customers for our products may be limited. We also face significant risks in the event any of our key customers is acquired by a company that has not adopted our technology or not adopted it to the same extent. In that event, we could face a significant decline in our sales to the acquired customer.
We experience significant fluctuations in sales and operating results from quarter to quarter.
     Our quarterly results fluctuate due to a number of factors, including:
    the lack of any contractual obligation by our customers to purchase their forecasted demand for our products;
 
    variations in the timing, cancellation, or rescheduling of customer orders and shipments; and
 
    high fixed expenses that may disproportionately impact operating expenses, especially during a quarter with a sales shortfall.
     The nature of our business requires that we promptly ship products after we receive orders. This means that we typically do not have a significant backlog of unfilled orders at the start of each quarter. Our major customers generally

8


Table of Contents

have no contractual obligation to purchase forecasted amounts and may cancel orders, change delivery schedules or change the mix of products ordered with minimal notice and minimal penalty. As a result of these factors, we may not be able to accurately predict our quarterly sales. Any shortfall in sales relative to our quarterly expectations or any delay of customer orders would adversely affect our revenues and results of operations.
     Order deferrals and cancellations by our customers, declining average sales prices, changes in the mix of products sold, increases in inventory and finished goods, delays in the introduction of new products and longer than anticipated sales cycles for our products have, in the past, adversely affected our results of operations. Despite these factors, we maintain significant finished goods, work-in-progress and raw materials inventory to meet estimated order forecasts. If our customers purchase less than the forecasted amounts or cancel or delay existing purchase orders, there will be higher levels of inventory that face a greater risk of obsolescence. If our customers desire to purchase products in excess of the forecasted amounts or in a different product mix, there may not be enough inventory or manufacturing capacity to fill their orders.
     Due to these and other factors, our past results may not be reliable indicators of our future performance. Future revenues and operating results may not meet the expectations of stock analysts and investors. In either case, the price of our common stock could be materially adversely affected.
Our sales cycles are unpredictable, making future performance uncertain.
     The sales cycle for telecommunications products includes identification of decision makers within the customers’ organizations, development of an understanding of customer-specific performance and economic issues, convincing the customer through field trial reports of the benefits of systems offered, negotiation of purchase orders and deployment. Customers who purchase our systems must commit a significant amount of capital and other resources. Our customers must consider budgetary constraints, comply with internal procedures for approving large expenditures and complete whatever testing is necessary for them to integrate new technologies that will impact their key operations. Customer delays can lengthen the sales cycles and have a material adverse effect on our business.
We depend on the capital spending patterns of wireless network operators, and if capital spending is decreased or delayed, our business may be harmed.
     Because we rely on wireless network operators for product purchases, any substantial decrease or delay in capital spending patterns in the wireless communication industry may harm our business. Demand from customers for our products depends to a significant degree upon the amount and timing of capital spending by these customers for constructing, rebuilding or upgrading their systems. The capital spending patterns of wireless network operators depend on a variety of factors, including access to financing, the status of federal, local and foreign government regulation and deregulation, changing standards for wireless technology, overall demand for wireless services, competitive pressures and general economic conditions. In addition, capital spending patterns in the wireless industry can be subject to some degree of seasonality, with lower levels of spending in the first and third calendar quarters, based on annual budget cycles.
Our reliance on a limited number of suppliers and the long lead time of components for our products could impair our ability to manufacture and deliver our systems on a timely basis.
     A number of components used in our products are available from only one or a limited number of outside suppliers due to unique designs as well as certain quality and performance requirements. We currently purchase substrates for growth of high-temperature superconductor thin-films from a single supplier because of the quality of those substrates. A thin film is a thin layer of high-temperature superconductor material. There are additional components that we source from a single vendor due to the present volume. Key components of our conventional products are manufactured by a sole foreign manufacturer. Our reliance on sole or limited source suppliers involves certain risks and uncertainties, many of which are beyond our control. These include the possibility of a shortage or the discontinuation of certain key components. Any reduced availability of these parts or components when required could impair our ability to manufacture and deliver our systems on a timely basis and result in the delay or cancellation of orders, which could harm our business.
     In addition, the purchase of some of our key components involves long lead times and, in the event of unanticipated increases in demand for our solutions, we may be unable to obtain these components in sufficient quantities to meet our customers’ requirements. We do not have guaranteed supply arrangements with any of these suppliers, do not maintain an

9


Table of Contents

extensive inventory of parts or components and customarily purchase sole or limited source parts and components pursuant to purchase orders. Business disruptions, quality issues, production shortfalls or financial difficulties of a sole or limited source supplier could materially and adversely affect us by increasing product costs, or eliminating or delaying the availability of such parts or components. In such events, our inability to develop alternative sources of supply quickly and on a cost-effective basis could impair our ability to manufacture and deliver our systems on a timely basis and could harm our business.
Our reliance on a limited number of suppliers exposes us to quality control issues.
     Our reliance on certain single-source and limited-source components exposes us to quality control issues if these suppliers experience a failure in their production process or otherwise fail to meet our quality requirements. A failure in single-source or limited-source components or products could force us to repair or replace a product utilizing replacement components. If we cannot obtain comparable replacements or effectively return or redesign our products, we could lose customer orders or incur additional costs, which could have a material adverse effect on our gross margins and results of operations.
We expect continued decreases in average selling prices, requiring us to reduce product costs in order to achieve and maintain profitability.
     The average selling price of our products has decreased over the years. We anticipate customer pressure on our product pricing will continue for the foreseeable future. We have plans to further reduce the manufacturing cost of our products, but there is no assurance that our future cost reduction efforts will keep pace with price erosion. We will need to further reduce our manufacturing costs through engineering improvements and economies of scale in production and purchasing in order to achieve adequate gross margins. We may not be able to achieve the required product cost savings at a rate needed to keep pace with competitive pricing pressure. Additionally, we may be forced to discount future orders. If we fail to reach our cost saving objectives or we are required to offer future discounts, our business may be harmed.
Our ability to protect our patents and other proprietary rights is uncertain, exposing us to possible losses of competitive advantage.
     Our efforts to protect our proprietary rights may not succeed in preventing infringement by others or ensure that these rights will provide us with a competitive advantage. Pending patent applications may not result in issued patents and the validity of issued patents may be subject to challenge. Third parties may also be able to design around the patented aspects of the products. Additionally, certain of the issued patents and patent applications are owned jointly with third parties. Because any owner or co-owner of a patent can license its rights under jointly-owned patents or applications, inventions made by us jointly with others are not subject to our exclusive control. Any of these possible events could result in losses of competitive advantage.
We depend on specific patents and licenses to technologies, and we will likely need additional technologies in the future that we may not be able to obtain.
     We utilize technologies under licenses of patents from others for our products. These patents may be subject to challenge, which may result in significant litigation expense (which may or may not be recoverable against future royalty obligations). Additionally, we continually try to develop new products, and, in the course of doing so, we may be required to utilize intellectual property rights owned by others and may seek licenses to do so. Such licenses may not be obtainable on commercially reasonable terms, or at all. It is also possible that we may inadvertently utilize intellectual property rights held by others, which could result in substantial claims.
Intellectual property infringement claims against us could materially harm results of operations.
     Our products incorporate a number of technologies, including high-temperature superconductor technology, technology related to other materials, and electronics technologies. Our patent positions, and that of other companies using high-temperature superconductor technology, is uncertain and there is significant risk that others, including our competitors or potential competitors, have obtained or will obtain patents relating to our products or technologies or products or technologies planned to be introduced by us.

10


Table of Contents

     We believe that patents may be or have been issued, or applications may be pending, claiming various compositions of matter used in our products. We may need to secure one or more licenses of these patents. There can be no assurances that such licenses could be obtained on commercially reasonable terms, or at all. We may be required to expend significant resources to develop alternatives that would not infringe such patents or to obtain licenses to the related technology. We may not be able to successfully design around these patents or obtain licenses to them and may have to defend ourselves at substantial cost against allegations of infringement of third party patents or other rights to intellectual property. In those circumstances, we could face significant liabilities and also be forced to cease the use of key technology.
We currently rely on specific technologies and may not successfully adapt to the rapidly changing wireless telecommunications equipment market.
     Wireless telecommunication equipment is characterized by rapidly advancing technology. Our success depends upon our ability to keep pace with advancing wireless technology, including materials, processes and industry standards. For example, we had to redesign our SuperLink product to convert from thallium barium calcium copper oxide to yttrium barium copper oxide in order to reduce the product cost and compete with other technologies. However, even with the lower cost HTS material, SuperLink may not ultimately prove commercially competitive against other current technologies or those that may be discovered in the future.
     We will have to continue to develop and integrate advances to our core technologies. We will also need to continue to develop and integrate advances in complementary technologies. We cannot guarantee that our development efforts will not be rendered obsolete by research efforts and technological advances made by others.
Other parties may have the right to utilize technology important to our business.
     We utilize certain intellectual property rights under non-exclusive licenses or have granted to others the right to utilize certain intellectual property rights licensed from a third party. Because we may not have the exclusive rights to utilize such intellectual property, other parties may be able to compete with us, which may harm our business.
Our failure to anticipate and respond to developments in the wireless telecommunications market could substantially harm our business.
     Our efforts are focused on the wireless telecommunications market, including the 2G, 2.5G and 3G markets. The dedication of our resources to the wireless telecommunications market makes us potentially vulnerable to changes in this market, such as new technologies like WIMAX, future competition, changes in availability of capital resources or regulatory changes that could affect the competitive position and rate of growth of the wireless industry.
We may not be able to compete effectively against alternative technologies.
     Our products compete with a number of alternative approaches and technologies that increase the capacity and improve the quality of wireless networks. Some of these alternatives may be more cost effective or offer better performance than our products. Wireless network operators may opt to increase the number of transmission stations, increase tower heights, install filters and amplifiers at the top of towers or use advanced antenna technology in lieu of purchasing our products. We may not succeed in competing against these alternatives.
We depend upon government contracts for a substantial amount of revenue and our business may suffer if significant contracts are terminated, adversely modified, or we are unable to win new contracts.
     We derive a substantial portion of our revenue from a few large contracts with the U.S. government. As a result, a reduction in, or discontinuance of, the government’s commitment to current or future programs could materially reduce government contract revenue.
     Contracts involving the U.S. government may include various risks, including:
    termination by the government;

11


Table of Contents

    reduction or modification in the event of changes in the government’s requirements or budgetary constraints;
 
    increased or unexpected costs causing losses or reduced profits under contracts where prices are fixed or unallowable costs under contracts where the government reimburses for costs and pays an additional premium;
 
    risks of potential disclosure of confidential information to third parties;
 
    the failure or inability of the main contractor to perform its contract in circumstances where we are a subcontractor;
 
    the failure of the government to exercise options for additional work provided for in the contracts; and
 
    the government’s right in certain circumstances to freely use technology developed under these contracts.
     The programs in which we participate may extend for several years, but are normally funded on an annual basis. The U.S. government may not continue to fund programs under which we have entered into contracts. Even if funding is continued, we may fail to compete successfully to obtain funding within such programs.
     All costs for services under government contracts are subject to audit, and the acceptance of such costs as allowable and allocable is subject to federal regulatory guidelines. We record contract revenues in amounts that we expect to be realized upon final audit settlement. Any disallowance of costs by the government could have an adverse effect on our business, operating results and financial condition. Audits and adjustments may result in decreased revenues and net income for those years. Additionally, because of our participation in government contracts, we are subject to audit from time to time for our compliance with government regulations by various agencies. Government agencies may conduct inquiries or investigations that may cover a broad range of activity. Responding to any such audits, inquiries or investigations may involve significant expense and divert management’s attention. In addition, an adverse finding in any such audit, inquiry or investigation could involve penalties that may harm our business.
Because competition for target employees is intense, we may be subject to claims of unfair hiring practices, trade secret misappropriation or other related claims.
     Companies in the wireless telecommunications industry whose employees accept positions with competitors frequently claim that competitors have engaged in unfair hiring practices, trade secret misappropriation or other related claims. We may be subject to such claims in the future as we seek to hire qualified personnel, and such claims may result in material litigation. If this should occur, we could incur substantial costs in defending against these claims, regardless of their merits.
If we are unable to forecast our inventory needs accurately, we may be unable to obtain sufficient manufacturing capacity or may incur unnecessary costs and produce excess inventory.
     We forecast our inventory needs based on anticipated purchase orders to determine manufacturing requirements. If we overestimate demand, we may have excess inventory, and our suppliers may as well, which could increase our costs. If we underestimate our requirements, our suppliers may have inadequate inventory, which could interrupt manufacturing and result in delays in shipments and recognition of revenues. In addition, lead times for ordering materials and components vary significantly and depend on factors such as the specific supplier, contract terms and demand for any component at a given time. Accordingly, if we inaccurately forecast demand, we may be unable to obtain adequate manufacturing capacity from our suppliers to meet customers’ delivery requirements, which would harm our business.
Our success depends on the attraction and retention of senior management and technical personnel with relevant expertise.
     As a competitor in a highly technical market, we depend heavily upon the efforts of our existing senior management and technical teams. The loss of the services of one or more members of these teams could slow product development and commercialization objectives. Due to the specialized nature of our products, we also depend upon our ability to attract and

12


Table of Contents

retain qualified technical personnel with substantial industry knowledge and expertise. Competition for qualified personnel is intense, and we may not be able to continue to attract and retain qualified personnel necessary for the development of our business.
     We have experienced difficulty recruiting senior management due to the high cost of living in the Santa Barbara area. We have a limited pool of qualified executives in Santa Barbara and may attempt to recruit qualified candidates from across the country. Some candidates have cited the high cost of housing in Santa Barbara as a significant negative factor when considering our employment offers. We have mitigated this problem to a limited extent by allowing some executives to maintain their existing residences in other parts of the country and effectively “commute” to our corporate headquarters in Santa Barbara as needed to perform their duties. Regardless, we expect the cost of housing in our area will continue to present a significant obstacle to recruiting senior executives.
Regulatory changes negatively affecting wireless communications companies could substantially harm our business.
     The Federal Communications Commission strictly regulates the operation of wireless base stations in the United States. Other countries also regulate the operation of base stations within their territories. Base stations and equipment marketed for use in base stations must meet specific technical standards. Our ability to sell our high-temperature superconductor filter subsystems will depend upon the rate of deployment of other new wireless digital services, the ability of base station equipment manufacturers and of base station operators to obtain and retain the necessary approvals and licenses, and changes in regulations that may impact the product requirements. Any failure or delay of base station manufacturers or operators in obtaining necessary approvals could harm our business.
We may acquire or make investments in companies or technologies that could cause loss of value to stockholders and disruption of business.
     We may explore opportunities to acquire companies or technologies in the future. Other than the acquisition of Conductus, Inc. in 2002, we have not made any such acquisitions or investments to date and, therefore, our ability as an organization to make acquisitions or investments is unproven. An acquisition entails many risks, any of which could adversely affect our business, including:
    failure to integrate operations, services and personnel;
 
    the price paid may exceed the value eventually realized;
 
    loss of share value to existing stockholders as a result of issuing equity securities to finance an acquisition;
 
    potential loss of key employees from either our then current business or any acquired business;
 
    entering into markets in which we have little or no prior experience;
 
    diversion of financial resources and management’s attention from other business concerns;
 
    assumption of unanticipated liabilities related to the acquired assets; and
 
    the business or technologies acquired or invested in may have limited operating histories and may be subjected to many of the same risks to which we are exposed.
     In addition, future acquisitions may result in potentially dilutive issuances of equity securities, or the incurrence of debt, contingent liabilities or amortization expenses or charges related to goodwill or other intangible assets, any of which could harm our business. As a result, if we fail to properly evaluate and execute acquisitions or investments, our business and prospects may be seriously harmed.

13


Table of Contents

If we are unable to implement appropriate controls and procedures to manage our potential growth, we may not be able to successfully offer our products and implement our business plan.
     Our ability to successfully offer our products and implement our business plan in a rapidly evolving market requires an effective planning and management process. Growth in future operations would place a significant strain on management systems and resources. We expect that we would need to improve our financial and managerial controls, reporting systems and procedures, and would need to expand, train and manage our work force worldwide. Furthermore, we expect that we would be required to manage multiple relationships with various customers and other third parties.
Compliance with environmental regulations could be especially costly due to the hazardous materials used in the manufacturing process.
     We are subject to a number of federal, state and local governmental regulations related to the use, storage, discharge and disposal of toxic, volatile or otherwise hazardous chemicals used in our business. Any failure to comply with present or future regulations could result in fines being imposed, suspension of production or interruption of operations. In addition, these regulations could restrict our ability to expand or could require us to acquire costly equipment or incur other significant expense to comply with environmental regulations or to clean up prior discharges.
The reliability of market data included in our public filings is uncertain.
     Since we operate in a rapidly changing market, we have in the past, and may from time to time in the future, include market data from industry publications and our own internal estimates in some of the documents we file with the Securities and Exchange Commission. The reliability of this data cannot be assured. Industry publications generally state that the information contained in these publications has been obtained from sources believed to be reliable, but that its accuracy and completeness is not guaranteed. Although we believe that the market data used in our filings with the Securities and Exchange Commission is and will be reliable, it has not been independently verified. Similarly, internal company estimates, while believed by us to be reliable, have not been verified by any independent sources.
Our international operations expose us to certain risks.
     In November 2007, we signed an agreement for a joint venture with BAOLI to manufacture and market our SuperLink® interference elimination solution for the China market. In additional to facing many of the risks faced by our domestic business, if that joint venture or any other international operation we may have is to be successful, we (together with any joint venture partner) must recruit the necessary personnel and develop the facilities needed to manufacture and sell the products involved, learn about the local market (which may significantly different from our domestic market), build brand awareness among potential customers and compete successfully with local organizations with greater market knowledge and potentially greater resources than we have. We must also obtain a number of critical governmental approvals from both the United States and the local country governments on a timely basis, including those related to any transfers of our technology. We must establish sufficient controls on any foreign operations to ensure that those operations are operated in accordance with our interests, that our intellectual property is protected and that our involvement does not inadvertently create potential competitors. There can be no assurance that these conditions will be met. Even if they are met, the process of building our international operations could divert financial resources and management attention from other business concerns. Finally, our international operations will also be subject to the general risks of international operations, such as:
    changes in exchange rates;
 
    international political and economic conditions;
 
    changes in government regulation in various countries;
 
    trade barriers;
 
    adverse tax consequences; and
 
    costs associated with expansion into new territories.

14


Table of Contents

Risks Related to Our Common Stock
Our stock price is volatile.
     The market price of our common stock has been, and we expect will continue to be, subject to significant volatility. The value of our common stock may decline regardless of our operating performance or prospects. Factors affecting our market price include:
    our perceived prospects;
 
    variations in our operating results and whether we have achieved key business targets;
 
    changes in, or our failure to meet, earnings estimates;
 
    changes in securities analysts’ buy/sell recommendations;
 
    differences between our reported results and those expected by investors and securities analysts;
 
    announcements of new contracts by us or our competitors;
 
    market reaction to any acquisitions, joint ventures or strategic investments announced by us or our competitors; and
 
    general economic, political or stock market conditions.
     Recent events have caused stock prices for many companies, including ours, to fluctuate in ways unrelated or disproportionate to their operating performance. The general economic, political and stock market conditions that may affect the market price of our common stock are beyond our control. The market price of our common stock at any particular time may not remain the market price in the future.
We have a significant number of outstanding warrants and options, and future sales of these shares could adversely affect the market price of our common stock.
     As of December 31, 2008, we had outstanding warrants and options exercisable for an aggregate of 1,586,491 shares of common stock at a weighted average exercise price of $18.82 per share. We have registered the issuance of all these shares, and they will be freely tradable by the exercising party upon issuance. The holders may sell these shares in the public markets from time to time, without limitations on the timing, amount or method of sale. As our stock price rises, the holders may exercise their warrants and options and sell a large number of shares. This could cause the market price of our common stock to decline.
Our corporate governance structure may prevent our acquisition by another company at a premium over the public trading price of our shares.
     It is possible that the acquisition of a majority of our outstanding voting stock by another company could result in our stockholders receiving a premium over the public trading price for our shares. Provisions of our restated certificate of incorporation and bylaws and of Delaware corporate law could delay or make more difficult an acquisition of our company by merger, tender offer or proxy contest, even if it would create an immediate benefit to our stockholders. For example, our restated certificate of incorporation does not permit stockholders to act by written consent and our bylaws generally require ninety days advance notice of any matters to be brought before the stockholders at an annual or special meeting.
     In addition, our board of directors has the authority to issue up to 2,000,000 shares of preferred stock and to determine the terms, rights and preferences of this preferred stock, including voting rights of those shares, without any further vote or action by the stockholders. In 2008, 611,523 of these shares were issued to BAOLI, and 1,388,477 shares currently remain unissued. The rights of the holders of common stock may be subordinate to, and adversely affected by, the rights of holders

15


Table of Contents

of preferred stock that may be issued in the future. The issuance of preferred stock could also make it more difficult for a third party to acquire a majority of our outstanding voting stock, even at a premium over our public trading price.
     Further, our certificate of incorporation also provides for a classified board of directors with directors divided into three classes serving staggered terms. These provisions may have the effect of delaying or preventing a change in control of us without action by our stockholders and, therefore, could adversely affect the price of our stock or the possibility of sale of shares to an acquiring person.
We do not anticipate declaring any cash dividends on our common stock.
     We have never declared or paid cash dividends on our common stock and do not plan to pay any cash dividends in the near future. Our current policy is to retain all funds and earnings for use in the operation and expansion of our business. In addition, our debt agreements prohibit the payment of cash dividends or other distributions on any of our capital stock except dividends payable in additional shares of capital stock.
ITEM 1B.   UNRESOLVED STAFF COMMENTS
          None.
ITEM 2.   PROPERTIES
     We lease all of our properties. All of our operations, including our manufacturing facility, are located in an industrial complex in Santa Barbara, California. We occupy approximately 71,000 square feet in this complex under a long-term lease that expires in 2011. Although we currently have excess capacity, we believe this facility can be managed in a flexible and cost effective manner and is adequate to meet current and reasonably anticipated needs for approximately the next two years.
ITEM 3.   LEGAL PROCEEDINGS
     We may be involved in routine litigation arising in the ordinary course of our business, and, while the results of the proceedings cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our financial position, operating results or cash flow.
ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
     No matters were submitted to our stockholders during the last quarter of 2008.
PART II
ITEM 5.   MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market for Common Stock
     Our common stock is traded on the NASDAQ Capital Market under the symbol “SCON.” The following table shows the high and low intraday sales prices for our common stock as reported by NASDAQ for each calendar quarter in the last two fiscal years:
                 
    High   Low
2008
               
Quarter ended March 29, 2008
  $ 6.80     $ 3.22  
Quarter ended June 28, 2008
  $ 4.83     $ 2.18  
Quarter ended September 27, 2008
  $ 2.43     $ 0.73  
Quarter ended December 31, 2008
  $ 1.50     $ 0.68  
 
               
2007
               
Quarter ended March 31, 2007
  $ 2.60     $ 1.60  
Quarter ended June 30, 2007
  $ 2.16     $ 1.40  
Quarter ended September 29, 2007
  $ 10.90     $ 1.38  
Quarter ended December 31, 2007
  $ 13.77     $ 5.50  

16


Table of Contents

Holders of Record
     We had 140 holders of record of our common stock on March 2, 2009. This number does not include stockholders for whom shares were held in a “nominee” or “street” name. We estimate that there are more than 15,000 beneficial owners of our common stock.
Dividends
     We have never paid cash dividends and intend to employ all available funds in the development of our business. We have no plans to pay cash dividends in the near future, and our line of credit does not allow the payment of dividends.
     Our ability to declare or pay dividends on shares of our common stock is subject to the requirement that we pay an equivalent dividend on each outstanding share of Series A Preferred Stock (on an as converted basis).
Sales of Unregistered Securities
     We did not conduct any offerings of equity securities during the fourth quarter of 2008 that were not registered under the Securities Act of 1933.
Repurchases of Equity Securities
     We did not repurchase any shares of our common stock during the fourth quarter of 2008.
Securities Authorized for Issuance Under Equity Compensation Plans
                         
                    Number of securities  
    Number of             remaining available  
    securities to be             for future issuance  
    issued upon     Weighted-average     under equity  
    exercise of     exercise price of     compensation plans  
    outstanding     outstanding     (excluding  
    options, warrants     options, warrants     securities reflected  
Plan Category   and rights     and rights     in column (a))  
 
                       
Equity compensation plans approved by security holders
    1,234,025     $ 22.18       1,066,019  
Equity compensation plans not approved by security holders
                 
 
                 
Total
    1,234,025     $ 22.18       1,066,019  
 
                 
Stock Performance Graph
     The stock performance graph and related information presented below shall not be deemed “soliciting material” or “filed” with the Securities and Exchange Commission or subject to Regulation 14A or 14C under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or to the liabilities of Section 18 of the Exchange Act, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except to the extent that we specifically request that such information be treated as soliciting material or specifically incorporate it by reference into such a filing.

17


Table of Contents

     The graph and table below compare the cumulative total stockholders’ return on our common stock since December 31, 2003 with the Nasdaq Composite Index, and the Nasdaq Telecommunications Index over the same period (assuming the investment of $100 in our common stock and in the two other indices, and reinvestment of all dividends).
(PERFORMANCE GRAPH)
                                                 
    31-Dec-03   31-Dec-04   31-Dec-05   31-Dec-06   31-Dec-07   31-Dec-08
Superconductor Technologies
  $ 100.00     $ 25.00     $ 7.73     $ 3.18     $ 9.98     $ 1.82  
Nasdaq Composite
    100.00       108.59       110.08       120.56       132.39       78.72  
Nasdaq-Telecommunications
    100.00       108.00       100.21       128.03       139.77       79.69  

18


Table of Contents

ITEM 6.   SELECTED FINANCIAL DATA
     The information set forth below is not necessarily indicative of results of future operations and should be read in conjunction with our Financial Statements and Notes thereto appearing in Item 15 of Part IV of this Report and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.
                                         
    Years Ended December 31,
    2004     2005     2006     2007     2008  
     
    (In thousands, except per share data)  
 
                                       
Statement of Operations Data:
                                       
Net revenues:
                                       
Net commercial product revenues
  $ 16,787     $ 21,080     $ 17,697     $ 12,787     $ 6,768  
Government contract revenues
    6,189       3,107       3,361       5,115       4,525  
Sub license royalties
    28       22       20              
 
                             
Total net revenues
    23,004       24,209       21,078       17,902       11,293  
 
                                       
Costs and expenses:
                                       
Cost of commercial product revenues
    23,421       18,989       15,922       12,944       8,911  
Contract research and development
    4,465       2,806       2,407       2,906       3,649  
Other research and development
    5,036       4,214       3,488       3,172       3,394  
Selling, general and administrative
    16,051       11,442       9,086       8,123       8,151  
Restructuring expenses and impairment charges
    4,128       1,197       38             141  
Write off of Goodwill
                20,107              
 
                             
Total costs and expenses
    53,101       38,648       51,048       27,145       24,246  
 
                             
 
                                       
Loss from operations
    (30,097 )     (14,439 )     (29,970 )     (9,243 )     (12,953 )
Other income (expense), net
    (1,120 )     226       346       117       252  
 
                             
 
                                       
Net loss
  $ (31,217 )   $ (14,213 )   $ (29,624 )   $ (9,126 )   $ (12,701 )
 
                             
 
                                       
Basic and diluted net loss per share:
                                       
 
                                       
Net loss per common share
  $ (3.71 )   $ (1.24 )   $ (2.37 )   $ (0.73 )   $ (0.77 )
 
                             
 
                                       
Weighted average number of shares Outstanding
    8,424       11,419       12,483       12,488       16,403  
                                         
    Years Ended December 31,
    2004   2005   2006   2007   2008
     
Balance Sheet Data:
                                       
Cash and cash equivalents
  $ 12,802     $ 13,018     $ 5,487     $ 3,939     $ 7,569  
Working capital
    16,146       17,218       10,158       3,293       12,253  
Total assets
    62,358       52,045       21,904       16,625       19,358  
Long-term debt, including current portion
    76       33       618       563       521  
Total stockholders’ equity
    49,249       47,257       17,951       9,190       17,552  

19


Table of Contents

ITEM 7.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
     This Management’s Discussion and Analysis of Financial Condition and Results of Operations includes many forward-looking statements. For cautions about relying on such forward looking statements, please refer to the section entitled “Forward Looking Statements” at the beginning of this Report immediately prior to Item 1.
General
     We are a leading company in high temperature superconductor (“HTS”) materials and related technologies. HTS materials have the unique ability to conduct various signals or energy (e.g., electrical current or radio frequency (“RF”) signals) with little or no resistance when cooled to “critical” temperatures. Electric currents that flow through conventional conductors encounter resistance that requires power to overcome and generates heat. HTS materials can substantially improve the performance characteristics of electrical systems, reducing power loss, lowering heat generation and decreasing electrical noise. Circuits designed to remove interference inherent in some RF signals can also be made from HTS materials. Commercial use of HTS materials requires a number of cutting edge technologies, including development of HTS materials, specialized manufacturing expertise to create uniform thin layers of these materials, expert designs of circuits optimized for HTS materials, and technologies to maintain an extremely low temperature environment for HTS applications (although the critical temperatures for HTS are “high” compared with traditional superconductors, they are still extremely cold by other standards).
Our Proprietary Technology
     We are focused on research and development to maintain our technological edge. As of December 31, 2008, we had 29 employees in our research and development division; eight of our employees have Ph.D.s, and 13 others hold advanced degrees in physics, materials science, electrical engineering and other fields. Our development efforts over the last 21 years have yielded an extensive patent portfolio as well as critical trade secrets, unpatented technology and proprietary knowledge. We enter into confidentiality and non-disclosure agreements with our employees, suppliers and consultants to protect our proprietary information. As of December 31, 2008, we held 57 U.S. patents in the following categories:
    7 patents for technologies directed toward producing thin-film materials and structures, which expire between 2010 and 2025. We have developed a proprietary state-of-the-art manufacturing process for producing HTS thin-films of the highest quality.
 
    29 patents for cryogenic and non-microwave circuit designs, which expire between 2010 and 2026. The expertise of our highly qualified team has allowed us to design and fabricate extremely small, high-performance circuits including RF signal filters.
 
    17 patents covering cryogenics, packaging and systems, which expire between 2013 and 2025. Our proprietary and patented cryogenic packaging innovation provides us with a significant competitive advantage in maintaining our HTS materials at their critical temperatures.
 
    4 patents covering other superconducting technologies, which expire between 2013 and 2015.
     As of December 31, 2008, we also had 15 issued foreign patents, 25 U.S. patent applications pending and 44 foreign applications patents pending.
     We are currently focusing our efforts on applications in areas such as:
    Wireless Networks. Our current commercial products help maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Our products increase capacity utilization, lower dropped and blocked calls, extend coverage, and enable higher wireless data throughput — all while reducing capital and operating costs.
 
    Reconfigurable Handset Filters. The trend in the wireless handset industry is to continually reduce size and cost, while adding more features and making the unit more adaptable to different air interfaces and frequencies throughout the world. This drives the need for more complex and reconfigurable transceivers. We believe our strong intellectual property and expertise in frequency agile and thin film filters position us well to meet this demand.
 
    Superconducting Power Transmission Lines. We have entered into a collaborative effort and signed a Material Transfer Agreement with the Department of Energy’s Los Alamos National Laboratory (“LANL”) to apply our

20


Table of Contents

      HTS expertise to LANL’s research initiative to develop HTS coated conductors for power transmission lines. If successfully developed, HTS superconducting cables could replace copper power transmission lines, resulting in higher capacity with less resistive cable losses.
 
    Government Products. As the worldwide leader in developing tunable HTS filter systems for military applications, we continue to be a crucial partner in the U.S. government’s future success. Our high-performance HTS filter systems have been proven to increase the detection range, reduce interference, and in some cases, detect signals that were previously undetectable with conventional technology. Currently, we actively participate in the development of technologies for application in military communications, signals intelligence, and electronic warfare.
     Our development efforts can take a significant number of years to commercialize, and we must overcome significant technical barriers and deal with other significant risks, some of which are set out in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
Our Business Model
     To be successful, we must use our expertise and our technology to generate revenues in various ways, including government contracts, commercial operations, joint ventures and licenses:
     Government Contracts
     We generate significant revenues from government contracts. We typically own the intellectual property developed under these contracts, and grant the Federal government a royalty-free, non-exclusive and nontransferable license to use it. As a result, our government contracts can not only generate a profit for us, but we can also make additional money through exploiting of the resulting technology in our commercial operations as well as government products, or through licenses or joint ventures. Contracts with the U.S. government contain provisions, and are subject to laws and regulations, that give the government rights and remedies not typically found in commercial contracts, including rights that allow the government to:
    terminate existing contracts for convenience, which affords the U.S. government the right to terminate the contract in            whole or in part anytime it wants for any reason or no reason, as well as for default;
 
    reduce or modify contracts or subcontracts, if its requirements or budgetary constraints change;
 
    cancel or reduce multi-year contracts and related orders, if funds for contract performance for any subsequent year become unavailable;
 
    adjust reimbursable contract costs and fees on the basis of audits completed by its agencies through exercise of its oversight rights; and
 
    control or prohibit the export of products.

21


Table of Contents

     Compensation in the event of a termination, if any, is limited to compensation for work completed at the time of termination. In the event of termination for convenience, we may receive a certain allowance for profit on the work performed.
     Commercial Applications
     We have chosen to manufacture and sell certain commercial products on our own. To date, our commercial efforts have been focused on the design, manufacture, and sale of high performance infrastructure products for wireless voice and data applications. We have three current product lines, all of which relate to wireless base stations:
    SuperLink, a highly compact and reliable receiver front-end HTS wireless filter system to eliminate out-of-band interference for wireless base stations, combining filters with a proprietary cryogenic cooler and a cooled low-noise amplifier.
 
    AmpLink, a ground-mounted unit for wireless base stations that includes a high-performance amplifier and up to six dual duplexers.
 
    SuperPlex, a high-performance multiplexer that provides extremely low insertion loss and excellent cross-band isolation designed to eliminate the need for additional base station antennas and reduce infrastructure costs.
     We sell most of our current commercial products to a small number of wireless carriers in the United States, including ALLTEL, AT&T, Sprint Nextel, T-Mobile and Verizon Wireless. Verizon Wireless and AT&T each accounted for more than 10% of our commercial revenues in 2008 and 2007. We are seeking to expand our customer base by selling directly to other wireless network operators and manufacturers of base station equipment, including internationally. Demand for wireless communications equipment fluctuates dramatically and unpredictably. The wireless communications infrastructure equipment market is extremely competitive and is characterized by rapid technological change, new product development, product obsolescence, evolving industry standards and price erosion over the life of a product. We face constant pressures to reduce prices. Consequently, we expect the average selling prices of our products will continue decreasing over time. We expect these trends to continue and may cause significant fluctuations in our quarterly and annual revenues. Our commercial operations are subject to a number of significant risks, some of which are set out in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
     Joint Ventures
     From time to time we may pursue joint ventures with other entities to commercialize our technology. In particular, we have agreed to license certain technology for our SuperLink® interference elimination solution for the China market to a joint venture where we own 45 percent of the equity. In the first quarter of 2008, we received orders from the joint venture for our new TD-SCDMA solution to perform lab trial and field trial activities in China. The lab trial was successfully completed in the second quarter of 2008, and the field trial was successfully completed during the fourth quarter of 2008. The commencement of manufacturing and the transfer of our processes to the joint venture will be driven by product demand from the China market. The joint venture’s activities remain subject to successful product marketing efforts in addition to a number of other conditions, including certain critical approvals from the Chinese and United States governments. In particular, we have been in discussions with the United States government concerning the national security implications of our joint venture and investment from BAOLI. There continues to be no assurance that these conditions will be met, or that all required approvals (if obtained) will be obtained on a timely basis. Even if these conditions are met and the approvals received, the results from our joint venture will be subject to a number of significant risks associated with international operations and new ventures, some of which are set forth in our public filings, including in particular the “Risk Factors” included in Item 1A of this Report.
     Licenses
     From time to time we grant licenses for our technology to other companies. Specifically, we have granted licenses to, among others, (1) Bruker for Nuclear Magnetic Resonance application, (2) General Dynamics for government applications and (3) Star Cryoelectronics for Superconducting Quantum Interference Device applications.

22


Table of Contents

Recent Developments
     Operating Lease
     In February 2009, we amended our office and production facilities lease. The base rent and the minimum annual escalation clause were reduced, and the term of the lease was extended five years to November 2016.
      Contract Funding
     In March 2009, the second phase of our U.S. Air Force contract was funded for an additional twelve months and provides for progress billing of up to $4.1 million.
Backlog
     Our commercial backlog consists of accepted product purchase orders with scheduled delivery dates during the next twelve months. We had commercial backlog of $272,000 at December 31, 2008, as compared to $352,000 at December 31, 2007.
Results of Operations
2008 Compared to 2007
     Net revenues decreased by $6.6 million, or 37%, to $11.3 million in 2008 from $17.9 million in 2007. Net revenues consist primarily of commercial product revenues and government contract revenues. We also generate some additional revenues from sublicensing our technology.
     Net commercial product revenues decreased by $6.0 million, or 47%, to $6.8 million in 2008 from $12.8 million in 2007. The decrease is primarily the result of lower sales volume for our products. Average sales prices for our products were essentially unchanged in 2008. Our two largest customers accounted for 92% of our net commercial revenues in 2008, as compared to 75% in 2007. These customers generally purchase products through non-binding commitments with minimal lead-times. Consequently, our commercial product revenues can fluctuate dramatically from quarter to quarter based on changes in our customers’ capital spending patterns.
     Government contract revenues decreased to $4.5 million in 2008 from $5.1 million in 2007, a decrease of $590,000, or 12%. This decrease is primarily attributable to the completion of the first phase of a major contract and a funding gap before the second phase of that contract was funded.
     Cost of commercial product revenues includes all direct costs, manufacturing overhead and provision for excess and obsolete inventories. The cost of commercial product revenues totaled $8.9 million for 2008 as compared to $12.9 million for 2007, a decrease of $4.0 million, or 31%. The lower costs resulted principally from lower production as a result of lower sales. Our expense provision for obsolete inventories totaled $17,000 in 2008 as compared to $160,000 in 2007.
     Our cost of sales includes both variable and fixed cost components. The variable component consists primarily of materials, assembly and test labor, overhead, which includes equipment and facility depreciation, transportation costs and warranty costs. The fixed component includes test equipment and facility depreciation, purchasing and procurement expenses and quality assurance costs. Given the fixed nature of such costs, the absorption of our production overhead costs into inventory decreases and the amount of production overhead variances expensed to cost of sales increases as production volumes decline since we have fewer units to absorb our overhead costs against. Conversely, the absorption of our production overhead costs into inventory increases and the amount of production overhead variances expensed to cost of sales decreases as production volumes increase since we have more units to absorb our overhead costs against. As a result, our gross profit margins generally decrease as revenue and production volumes decline due to lower sales volume and higher amounts of production overhead variances expensed to cost of sales; and our gross profit margins generally increase as our revenue and production volumes increase due to higher sales volume and lower amounts of production overhead variances expensed to cost of sales. Our inventory is valued at the lower of its actual cost or the current estimated market value of the

23


Table of Contents

inventory. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. If the results of the review determine that a write-down is necessary, we recognizes a loss in the period in which the loss is identified, whether or not the inventory is retained.
     The following is an analysis of our commercial product gross profit margins for 2007 and 2008:
                                 
    Years Ended December 31,  
Dollars in Thousands   2007     2008  
Net commercial product sales
  $ 12,787       100.0 %   $ 6,768       100.0 %
Cost of commercial product sales
    12,944       101.2 %     8,911       131.7 %
 
                       
Gross profit
  $ (157 )     (1.2 %)   $ (2,143 )     (31.7 %)
 
                       
     We had a negative gross margin of $2.1 million in 2008 from the sale of our commercial products as compared to a negative gross margin of $157,000 in 2007. The negative gross margin in 2008 is primarily because the reduced level of commercial sales was insufficient to cover our fixed manufacturing overhead costs. Our gross margins were also adversely impacted by a $17,000 charge for excess and obsolete inventory in 2008 and a similar charge of $160,000 in 2007. Gross margins were favorably impacted by $195,000 in 2007 by the sale of previously written-off inventory. There was no similar benefit in 2008. We regularly review inventory quantities on hand and provide an allowance for excess and obsolete inventory based on numerous factors, including sales backlog, historical inventory usage, forecasted product demand and production requirements for the next twelve months.
     Contract research and development expenses totaled $3.6 million in 2008 as compared to $2.9 million in 2007, an increase of $743,000 or 26%. As a percentage of government revenue, contract research and development expenses increased from 57% in 2007 to 81% in 2008 because of different cost recognition criteria on one of our 2008 cost-plus contracts.
     Other research and development expenses relate to development of new wireless commercial products and other products related to our expertise. We also incur design expenses associated with reducing the cost and improving the manufacturability of our existing products. These expenses totaled $3.4 million in 2008 compared to $3.2 million in 2007, an increase of $222,000, or 7%. The increase is due to increased efforts associated with new commercial products development.
     Selling, general and administrative expenses totaled $8.2 million in 2008 as compared to $8.1 million in 2007, an increase of $28,000, or less than 1%. Expenses were lower in 2007 primarily from reversal of a $610,000 reserve in the first quarter of 2007. In 2008 we had lower insurance premiums and lower selling expenses that were slightly offset by higher legal expenses associated with our China joint venture.
     In the fourth quarter of 2008 we reduced our work force and incurred a $141,000 severance charge. There was no similar charge in 2007.
     Interest income increased to $284,000 in 2008, as compared to $156,000 in 2007, primarily because of higher cash balances in 2008.
     Interest expense in 2008 amounted to $32,000, as compared to $39,000 in 2007, as a result of lower borrowing levels.
     Our loss totaled $12.7 million in 2008, as compared to $9.1 million in 2007.
     The net loss available to common stockholders totaled $0.77 per common share in 2008, as compared to $0.73 per common share in 2007.
2007 Compared to 2006
     Net revenues decreased by $3.2 million, or 15%, from $21.1 million in 2006 to $17.9 million in 2007.

24


Table of Contents

     Net commercial product revenues decreased by $4.9 million, or 28%, to $12.8 million in 2007 from $17.7 million in 2006. The decrease is primarily the result of lower sales volume for some or our products. Average sales prices for our products decreased only slightly in 2007. Our two largest customers accounted for 75% of our net commercial revenues in 2007, as compared to 76% in 2006. These customers generally purchase products through non-binding commitments with minimal lead-times. Consequently, our commercial product revenues can fluctuate dramatically from quarter to quarter based on changes in our customers’ capital spending patterns.
     Government contract revenues increased to $5.1 million in 2007 from $3.4 million in 2006, an increase of $1.7 million, or 52%. This increase is primarily attributable to the addition of new or amended contracts in 2007.
     The cost of commercial product revenues totaled $12.9 million for 2007 as compared to $15.9 million for 2006, a decrease of $3.0 million, or 19%. The lower costs resulted principally from lower production as a result of lower sales. In addition, with lower production, we had fewer units to absorb our fixed overhead costs. Our provision for obsolete inventories decreased to $160,000 in 2007 as compared to $360,000 in 2006.
     The following is an analysis of our commercial product gross profit margins for 2006 and 2007:
                                 
    Years Ended December 31,  
Dollars in Thousands   2006     2007  
Net commercial product sales
  $ 17,697       100.0 %   $ 12,787       100.0 %
Cost of commercial product sales
    15,922       90 %     12,944       101.2 %
 
                       
Gross profit
  $ 1,775       10 %   $ (157 )     (1.2 %)
 
                       
     We had a negative gross margin of $157,000 in 2007 from the sale of our commercial products as compared to a positive gross margin of $1.8 million in 2006. We experienced negative gross profits in 2007 primarily because the reduced level of commercial sales was insufficient to cover our fixed manufacturing overhead costs. Our gross margins were also adversely impacted by a $160,000 charge for excess and obsolete inventory. Gross margins were favorably impacted by $195,000 in 2007 and $700,000 in 2006 by the sale of previously written-off inventory. We regularly review inventory quantities on hand and provide an allowance for excess and obsolete inventory based on numerous factors, including sales backlog, historical inventory usage, forecasted product demand and production requirements for the next twelve months.
     Contract research and development expenses totaled $2.9 million in 2007 as compared to $2.4 million in 2006, an increase of $499,000 or 21%. The increase was primarily the result of higher expenses associated with performing a greater number of government contracts. As a percentage of Government contract revenues, contract research and development expenses was 72% in 2006 and 57% in 2007.
     Other research and development expenses relate to development of new wireless commercial products. We also incur design expenses associated with reducing the cost and improving the manufacturability of our existing products. These expenses totaled $3.2 million in 2007 as compared to $3.5 million in 2006, a decrease of $316,000, or 9%. The decrease is due to lower expenses associated with commercial products development and the result of our cost reduction efforts.
     Selling, general and administrative expenses totaled $8.1 million in 2007 as compared to $9.1 million in 2006, a decrease of $1.0 million, or 11%. The lower expenses resulted primarily from $610,000 received from a settlement agreement with a former director and lower insurance premiums.
     In connection with the acquisition of Conductus in December 2002 we recognized $20.1 million of goodwill. At July 1, 2006, we concluded that our declining stock price constituted an event under FAS 142 and required us to test for goodwill impairment. Our analysis led us to reasonably estimate at that time that our fair market value was less than our net assets excluding goodwill. Accordingly, we recorded a full write-down of the goodwill ($20.1 million) in the second quarter of 2006. We also recorded an impairment charge of $38,000 related to a note receivable from a Board member in 2006.
     Interest income decreased to $156,000 in 2007, as compared to $391,000 in 2006, primarily because of lower cash balances in 2007.

25


Table of Contents

     Interest expense in 2007 amounted to $39,000, as compared to $45,000 in 2006, as a result of lower borrowing levels.
     Our loss totaled $9.1 million in 2007 as compared to $29.6 million in 2006.
     The net loss available to common stockholders totaled $0.73 per common share in 2007, as compared to $2.37 per common share in 2006.
Liquidity and Capital Resources
Cash Flow Analysis
     As of December 31, 2008, we had working capital of $12.3 million, including $7.6 million in cash and cash equivalents, as compared to working capital of $3.3 million at December 31, 2007, which included $3.9 million in cash and cash equivalents. We currently invest our excess cash in short-term, investment-grade, money-market instruments with maturities of three months or less. Our investments have no exposure to the auction rate securities market. We believe that all of our cash investments would be readily available to us should the need arise.
     Cash and cash equivalents increased by $3.7 million from $3.9 million at December 31, 2007 to $7.6 million at December 31, 2008. Cash was used principally in operations and to a lesser extent for our joint venture and the purchase of property and equipment. These uses were offset by gross cash proceeds of $16.5 million provided by the sales of common and preferred stock.
     Cash used in operations totaled $12.1 million in 2008. We used $10.4 million to fund the cash portion of our net loss. We also used cash to fund a $3.8 million increase in inventory, accounts payable payments, patents and licenses payments and prepaid and other current asset payments. These uses were offset by cash generated from lower accounts receivable and other assets totaling $2.1 million.
     Net cash used in investing activities totaled $700,000 in 2008. We invested $521,000 in our joint venture and we purchased $179,000 in fixed assets.
     Net cash provided by financing activities totaled $16.5 million in 2008. The cash was provided by $10.9 million, net of $89,000 in expenses, from the final payments under the $15.0 million August 2007 BAOLI investment and $5.6 million, net of $442,000 in expenses, from the sale of 2,000,000 shares of common stock at $3.00 per share in May 2008. Net cash provided by financing activities totaled $4.0 million in 2007.
Financing Activities
     We have historically financed our operations through a combination of cash on hand, equipment lease financings, available borrowings under bank lines of credit and both private and public equity offerings. We have effective registration statements on file with the Securities and Exchange Commission covering the public resale by investors of common stock issued in our private placements, as well as common stock acquired upon exercise of warrants.
     As described above, we completed two financing activities in 2008 totaling $16.5 million: the balance of the $15.0 million BAOLI investment and a $5.6 million offering of common stock in May 2008.
     In 2007, we did not complete a financing transaction. However, in 2007, we received $4.0 million from BAOLI as an installment toward completion of a $15.0 million financing completed in February 2008.
     We have an existing line of credit from a bank. The line of credit expires in July 2009. The loan agreement is structured as a sale of our accounts receivable and provides for the sale of up to $5.0 million of eligible accounts receivable, with advances to us totaling 80% of the receivables sold. Advances bear interest at the prime rate (3.25% at December 31, 2008) plus 2.50% subject to a minimum monthly charge. Advances are collateralized by a lien on all of our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions. There was no amount outstanding under this borrowing facility at December 31, 2008.

26


Table of Contents

Contractual Obligations and Commercial Commitments
     We incur various contractual obligations and commercial commitments in our normal course of business. They consist of the following:
    Operating Lease Obligations
     Our operating lease obligations consist of a facility lease in Santa Barbara, California and several copier leases.
    Patents and Licenses
     We have entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Some of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. Typically, the licensor can terminate our license if we fail to pay minimum annual royalties.
    Purchase Commitments
     In the normal course of business, we incur purchase obligations with vendors and suppliers for the purchase of inventory, as well as other goods and services. These obligations are generally evidenced by purchase orders that contain the terms and conditions associated with the purchase arrangements. We are committed to accept delivery of such material pursuant to the purchase orders subject to various contract provisions that allow us to delay receipt of such orders or cancel orders beyond certain agreed upon lead times. Cancellations may result in cancellation costs payable by us.
    Quantitative Summary of Contractual Obligations and Commercial Commitments
     At December 31, 2008, we had the following contractual obligations and commercial commitments:
                                         
    Payments Due by Period
                  2010 and     2012 and     2014 and  
Contractual Obligations   Total     2009     2011     2013     beyond  
 
Operating leases
  $ 4,463,000     $ 1,480,000     $ 2,973,000     $ 10,000        
Minimum license commitment
    1,650,000       150,000       300,000       300,000       900,000  
Fixed asset and inventory purchase commitments
    310,000       310,000                    
 
                             
Total contractual cash obligations
  $ 6,423,000     $ 1,940,000     $ 3,273,000     $ 310,000     $ 900,000  
 
                             
Capital Expenditures
     We plan to invest approximately $270,000 in fixed assets during 2009.
Future Liquidity
     In 2008, we incurred a net loss of $12.7 million and had negative cash flows from operations of $12.1 million. In 2007, we incurred a net loss of $9.1 million and had negative cash flows from operations of $5.4 million. Our independent registered public accounting firm has included in their audit reports for fiscal 2008 through 2006 an explanatory paragraph expressing doubt about our ability to continue as a going concern.
     At December 31, 2008 we had $7.6 million in cash. Our cash resources, together with our line of credit, and a planned inventory reduction, may not be sufficient to fund our business through 2009. We believe one of the key factors to our liquidity will be our ability to successfully execute on our plans to increase sales levels in a highly concentrated industry where we experience significant fluctuations in sales from quarter to quarter. Our cash requirements will also depend on

27


Table of Contents

numerous other variable factors, including the rate of growth of sales, the timing and levels of products purchased, payment terms and credit limits from manufacturers, and the timing and level of accounts receivable collections. Because of the uncertainty of these many factors, we may need to raise funds in the next six months to meet our working capital needs.
     We cannot assure you that additional financing will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.
Net Operating Loss Carryforward
     As of December 31, 2008, we had net operating loss carryforwards for federal and state income tax purposes of approximately $291.4 million and $168.8 million, respectively, which expire in the years 2009 through 2028. Of these amounts, $88.3 million and $23.5 million, respectively, resulted from the acquisition of Conductus. Included in the net operating loss carryforwards are deductions related to stock options of approximately $24.1 million and $13.1 million for federal and California income tax purposes, respectively. To the extent net operating loss carryforwards are recognized for accounting purposes, the resulting benefits related to the stock options will be credited to stockholders’ equity. In addition, we had research and development and other tax credits for federal and state income tax purposes of approximately $3.0 million and $1.4 million, respectively, which expire in the years 2009 through 2028. Of these amounts, $661,000 and $736,000, respectively, resulted from the acquisition of Conductus.
     Due to the uncertainty surrounding their realization, we have recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying balance sheet.
     Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return (usually the “applicable federal funds rate”, as defined in the Internal Revenue Code) and the value of the corporation at the time of a “change of ownership” as defined by Section 382. We had changes in ownership in August 1999 and December 2002. In addition, we acquired the right to Conductus’ net operating losses, which are also subject to the limitations imposed by Section 382. Conductus underwent three ownership changes, which occurred in February 1999, February 2001 and December 2002. Therefore, the ability to utilize our net operating loss carryforwards of $94.3 million and Conductus’ net operating loss carryforwards of $83.7 million incurred prior to the ownership changes will be subject in future periods to annual limitations of $1.3 million and $700,000, respectively. Net operating losses incurred by us subsequent to the ownership changes totaled $113.4 million and are not subject to this limitation.
Recent Accounting Pronouncements
     Recent accounting pronouncements are detailed in Note 2 to our Consolidated Financial Statements included in this Report.
Market Risk
     We are exposed to various market risks, including changes in interest rates. Market risk is the potential loss arising from adverse changes in market rates and prices. We do not enter into derivatives or other financial instruments for trading or speculation purposes. Our money market investments have no exposure to the auction rate securities market.
     At December 31, 2008, we had approximately $7.2 million invested in a money market account yielding approximately 1.72%. Assuming a 1% per annum decrease in the yield on this money market account and no liquidation of principal for the year, our total interest income would decrease by approximately $72,000 per annum. As we had no amounts outstanding on our bank loan during 2008, changes in its interest rate would not have affected us.
Inflation
     We do not foresee any material impact on our operations from inflation.

28


Table of Contents

Critical Accounting Policies and Estimates
     Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We continually evaluate our estimates, including those related to bad debts, inventories, recovery of long-lived assets, income taxes, warranty obligations, contract revenue and contingencies. We base our estimates on historical experience and on various other assumptions that we believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Any future changes to these estimates and assumptions could cause a material change to our reported amounts of revenues, expenses, assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.
     We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of the financial statements. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We write down our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.
     Our inventory is valued at the lower of its actual cost or the current estimated market value of the inventory. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. If the results of the review determine that a write-down is necessary, we recognize a loss in the period in which the loss is identified, whether or not the inventory is retained. Our inventory reserves establish a new cost basis for inventory and are not reversed until we sell or dispose of the related inventory. Such provisions are established based on historical usage, adjusted for known changes in demands for such products, or the estimated forecast of product demand and production requirements. Our business is characterized by rapid technological change, frequent new product development and rapid product obsolescence that could result in an increase in the amount of obsolete inventory quantities on hand. Demand for our products can fluctuate significantly. Our estimates of future product demand may prove to be inaccurate, and we may understate or overstate the provision required for excess and obsolete inventory.
     Our net sales consist of revenue from sales of products, net of trade discounts and allowances. We recognize revenue when evidence of an arrangement exists, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. At the time revenue is recognized, we provide for the estimated cost of product warranties if allowed for under contractual arrangements and return products. Our warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should such failure rates or costs differ from these estimates, accrued warranty costs would be adjusted.
     We indemnify, without limit or term, our customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our guarantees because of the uncertainty as to whether a claim might arise and how much it might total.
     Contract revenues are principally generated under research and development contracts. Contract revenues are recognized utilizing the percentage-of-completion method measured by the relationship of costs incurred to total estimated contract costs. If the current contract estimate were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for the total anticipated loss. Contract revenues are derived primarily from research contracts with agencies of the United States Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. These contracts include cost-plus, fixed price and cost sharing arrangements and are generally short-term in nature.
     All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical experience and review of current projects in process,

29


Table of Contents

we believe that the audits will not have a significant effect on our financial position, results of operations or cash flows. The Defense Contract Audit Agency has audited us through 2003.
     We periodically evaluate the realizability of long-lived assets as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in our business are written off in the period identified since they will no longer generate any positive cash flows for us. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. Our future cash flows may vary from estimates.
     We apply the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 123R, “Share-Based Payment,” which establishes the accounting for stock-based awards. Under this method, stock-based employee compensation cost is recognized using the fair-value based method for all awards granted on or after the beginning of fiscal year 2006. We issue stock option awards and restricted share awards to employees and to non-employee directors under our stock-based incentive plans. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model. Compensation cost related to restricted share awards is recorded based on the market price of our common stock on the grant date. We recognize compensation expense over the expected vesting period on a straight-line basis from the grant date. Our valuation allowance against the deferred tax assets is based on our assessments of historical losses and projected operating results in future periods. If and when we generate future taxable income in the U.S. against which these tax assets may be applied, some portion or all of the valuation allowance would be reversed and an increase in net income would consequently be reported in future years.
     We have a contract to deliver several custom products to a government contractor, with respect to which delivery of the product was delayed because we were unable to manufacture the products for technical reasons. In December 2008, new terms and amended specifications were agreed upon, and we now expect to deliver these custom products in July 2009.
ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Market Risk.”
ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
     All information required by this item is listed in the Index to Financial Statements in Part IV, Item 15(a)1 of this Report.
ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
     Not applicable.
ITEM 9A(T).   CONTROLS AND PROCEDURES
Controls and Procedures
     We have established disclosure controls and procedures to ensure that material information relating to us and our consolidated subsidiaries is made known to the officers who certify the Company’s financial reports, as well as other members of senior management and the Board of Directors, to allow timely decisions regarding required disclosures. As of the end of the period covered by this report we carried out an evaluation under the supervision and with the participation of our management, including the our Chief Executive Officer and Controller (“Principal Financial Officer”), of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 of the Securities and Exchange Act of 1934. Based upon that evaluation, the Chief Executive Officer and Controller concluded that our disclosure controls and procedures are effective in timely alerting them to material information related to us that is required to be included in our annual and periodic Securities and Exchange Commission filings.
     There were no changes in our internal controls over financial reporting during the fourth quarter of the year ended December 31, 2008 that have materially affected, or are reasonably likely to materially affect our internal controls over financial reporting.

30


Table of Contents

     We do not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.
Management’s Report on Internal Control Over Financial Reporting
     The report below shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that we specifically incorporate it by reference into such a filing.
     Our management is responsible for establishing and maintaining adequate internal control over our financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended). Our management assessed the effectiveness of our internal controls over financial reporting as of December 31, 2008. In making its assessment of the effectiveness of our internal controls over financial reporting, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. Based on these criteria, our management has concluded that, as of December 31, 2008, our internal control over financial reporting are effective. This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the company to provide only management’s report in this annual report.
ITEM 9B.   OTHER INFORMATION
None.
PART III
ITEM 10.   DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
     We have a Code of Business Conduct and Ethics for all of our employees, including our Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer. The purpose of the code is to ensure that our business is conducted in a consistently legal and ethical matter. We have posted the text of the code on our website at www.suptech.com. We will post any material amendments or waivers to the code on our website. We will provide a copy of our code free of charge to any person upon request by writing to us at the following address: Superconductor Technologies Inc., 460 Ward Drive, Santa Barbara, California 93111-2310, Attn: Corporate Secretary.
     All of the other information required by this Item is incorporated by reference to our Proxy Statement for the 2009 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days after the end of our year ended December 31, 2008.
ITEM 11.   EXECUTIVE COMPENSATION
     The information required by this item is incorporated by reference to our Proxy Statement for the 2009 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days after the end of our year ended December 31, 2008.
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
     The information required by this item is incorporated by reference to our Proxy Statement for the 2009 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days after the end of our year ended December 31, 2008.

31


Table of Contents

ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
     The information required by this item is incorporated by reference to our Proxy Statement for the 2009 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days after the end of our year ended December 31, 2008.
ITEM 14.   PRINCIPAL ACCOUNTING FEES AND DISCLOSURES
     The information required by this item is incorporated by reference to our Proxy Statement for the 2009 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days after the end of our year ended December 31, 2008.
PART IV
ITEM 15.   EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
     (a) The following documents are filed as part of this Report:
          1. Index to Financial Statements. Our financial statements and the Report of Stonefield Josephson, Inc., Independent Registered Public Accounting Firm are included in Part IV of this Report on the pages indicated:
     
    Page
  F-1
  F-2
  F-3
  F-4
  F-5
  F-6
          2. Financial Statement Schedule Covered by the Foregoing Report of Independent Registered Public Accounting Firm.
     
  F-23
All other schedules are omitted because they are not applicable or the required information is shown in the financial statements or the notes thereto.
          3. Exhibits
     
Number   Description of Document
 
   
3.1
  Amended and Restated Certificate of Incorporation of Registrant (2)
 
   
3.2
  Certificate of Amendment of Restated Certificate of Incorporation (5)
 
   
3.3
  Certificate of Amendment of Restated Certificate of Incorporation (17)
 
   
3.4
  Certificate of Designations of Registrant relating to the Series A Convertible Preferred Stock (22)
 
   
3.5
  Amended and Restated Bylaws of Registrant (14)
 
   
4.1
  Form of Common Stock Certificate (23)
 
   
4.2
  Form of Warrant to Purchase Common Stock dated March 28, 2003, issued to Silicon Valley Bank (7)
 
   
4.3
  Form of Warrant dated August 2005 (15)

32


Table of Contents

     
Number   Description of Document
 
10.1
  1992 Stock Option Plan (23) ***
 
   
10.2
  Form of 1992 Stock Option Agreement (23) ***
 
   
10.3
  1992 Director Option Plan (as amended through January 1997) (1)
 
   
10.4
  Form of 1992 Director Stock Option Agreement (1)
 
   
10.5
  1998 Non-Statutory Stock Option Plan, including Form of Stock Option Agreement (4)***
 
   
10.6
  1999 Stock Option Plan (3) ***
 
   
10.7
  Form of 1999 Stock Option Agreement (3) ***
 
   
10.8
  Form of Change in Control Agreement dated March 28, 2003 (7) ***
 
   
10.9
  Form of Amendment No. 1 to Change in Control Agreement dated as of May 24, 2005 (16) ***
 
   
10.10
  Form of Amendment No. 2 to Change in Control Agreement dated as of December 31, 2006 (19) ***
 
   
10.11
  Accounts Receivable Purchase Agreement by and between Registrant and Silicon Valley Bank dated March 28, 2003 (7)
 
   
10.12
  Accounts Receivable Purchase Modification Agreement by and between Registrant and Silicon Valley Bank dated March 17, 2004 (9)
 
   
10.13
  Accounts Receivable Purchase Modification Agreement by and between Registrant and Silicon Valley Bank dated March 16, 2005 (13)
 
   
10.14
  Accounts Receivable Purchase Modification Agreement by and between Registrant and Silicon Valley Bank dated July 13, 2008 (23)
 
   
10.15
  Patent License Agreement by and between Registrant and Lucent Technologies (8) **
 
   
10.16
  License Agreement between Registrant and Sunpower dated May 2, 2005 (10) **
 
   
10.17
  Employment Agreement between Registrant and Jeffrey Quiram dated as of February 14, 2005 (11) ***
 
   
10.18
  Option Agreement between Registrant and Jeffrey Quiram dated February 14, 2005 (11) ***
 
   
10.19
  Amendment to Employment Agreement between Registrant and Jeffrey Quiram dated as of December 31, 2006 (19) ***
 
   
10.20
  2003 Equity Incentive Plan (as amended May 25, 2005) (14) ***
 
   
10.21
  Form of Option Agreement for 2003 Equity Incentive Plan (11) ***
 
   
10.22
  Management Incentive Plan (18) ***
 
   
10.23
  Employment Agreement between Registrant and Terry White dated as of April 11, 2005 (12) ***
 
   
10.24
  Amendment to Employment Agreement between Registrant and Terry White dated as of December 31, 2006 (19) ***
 
   
10.25
  Form of Director and Officer Indemnification Agreement (16)
 
   
10.26
  Code of Business Conduct and Ethics (15)
 
   
10.27
  Lease Agreement between the Registrant and 1200 Enterprises LLC dated as of June 1, 2001 (6)
 
   
10.28
  Investment agreement between Registrant and Hunchun BaoLi Communication Co. Ltd. (“BAOLI”) dated August 17, 2007 (20)
 
   
10.29
  First amendment to investment agreement between Registrant and BAOLI dated November 9, 2007 (21)
 
   
10.30
  Second amendment to investment agreement between Registrant and BAOLI dated January 8, 2008 (21)
 
   
10.31
  Framework Agreement between Registrant and BAOLI dated November 8, 2007 (21)
 
   
10.32
  Sino-Foreign Equity Joint Venture between Superconductor Investments (Mauritius) Limited and BAOLI dated December 8, 2007 (Exhibit A to Framework Agreement with BAOLI) (21)
 
   
10.33
  Form of License Agreement between Registrant and BAOLI (Exhibit B to Framework Agreement) (21)
 
   
21
  List of Subsidiaries (23)

33


Table of Contents

     
Number   Description of Document
 
   
23.1
  Consent of Stonefield Josephson Inc, Independent Registered Public Accounting Firm (23)
 
   
31.1
  Statement of CEO Pursuant to 302 of the Sarbanes-Oxley Act of 2002 (23)
 
   
31.2
  Statement of CFO Pursuant to 302 of the Sarbanes-Oxley Act of 2002 (23)
 
   
32.1
  Statement of CEO Pursuant to 906 of the Sarbanes-Oxley Act of 2002 (23)
 
   
32.2
  Statement of CFO Pursuant to 906 of the Sarbanes-Oxley Act of 2002 (23)
 
(1)   Incorporated by reference from Registrant’s Registration Statement on Form S-8 filed April 15, 1998 (Reg. No. 33-50137).
 
(2)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended April 3, 1999.
 
(3)   Incorporated by reference from Registrant’s Registration Statement on Form S-8 filed November 4, 1999 (Reg. No. 333-90293).
 
(4)   Incorporated by reference from Registrant’s Registration Statement on Form S-8 filed March 6, 2001 (Reg. No. 333-56606).
 
(5)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2001.
 
(6)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2002.
 
(7)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 29, 2003.
 
(8)   Incorporated by reference from Registrant’s Annual Report on Form 10-K for the year ended December 31, 2003.
 
(9)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended April 3, 2004.
 
(10)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2004
 
(11)   Incorporated by reference from Registrant’s Annual Report on Form 10-K for the year ended December 31, 2004.
 
(12)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended April 2, 2005.
 
(13)   Incorporated by reference from Registrants’ Current Report on Form 8-K filed April 4, 2005.
 
(14)   Incorporated by reference from Registrant’s Current Report on Form 8-K filed May 27, 2005.
 
(15)   Incorporated by reference from Registrant’s Current Report on Form 8-K filed August 11, 2005.
 
(16)   Incorporated by reference from Registrant’s Annual Report on Form 10-K for the year ended December 31, 2005
 
(17)   Incorporated by reference from Registrant’s Current Report on Form 8-K filed March 13, 2006.
 
(18)   Incorporated by reference from Registrant’s Current Report on Form 8-K filed July 28, 2006.
 
(19)   Incorporated by reference from Registrant’s Annual Report on Form 10-K for the year ended December 31, 2006
 
(20)   Incorporated by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 29, 2007.
 
(21)   Incorporated by reference from Registrant’s Annual Report on Form 10-K for the year ended December 31, 2007.
 
(22)   Incorporated by reference from Registrant’s Current Report on Form 8-K/A filed February 25, 2008.
 
(23)   Filed herewith.
 
**   Confidential treatment has been previously granted for certain portions of these exhibits.
 
***   This exhibit is a management contract or compensatory plan or arrangement.
     (b) Exhibits. See Item 15(a) above.

34


Table of Contents

Report of Independent Registered Public Accounting Firm
To: The Board of Directors and Stockholders of Superconductor Technologies, Inc.
Santa Barbara, California
We have audited the accompanying consolidated balance sheets of Superconductor Technologies, Inc. (the “Company”) and its subsidiaries as of December 31, 2008 and 2007, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2008. Our audits also included the consolidated financial statement schedule listed in the Index at Item 15(a)(2) as of and for the three years ended December 31, 2008. These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company and its subsidiaries as of December 31, 2008 and 2007, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2008 in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the related consolidated financial statement schedule as of and for the three years ended December 31, 2008, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. As discussed in Note 2, the Company has incurred significant net losses since its inception and has an accumulated deficit of $212,686,000 and expects to incur substantial additional losses and costs. The foregoing matters raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are described in Note 2 of the accompanying financial statements. These financial statements do not include any adjustments that might result from the outcome of these uncertainties.
/s/ Stonefield Josephson, Inc.
Los Angeles, California
March 19, 2009

F-1


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.
CONSOLIDATED BALANCE SHEETS
                 
    December 31,     December 31,  
    2007     2008  
ASSETS                
Current Assets:
               
Cash and cash equivalents
  $ 3,939,000     $ 7,569,000  
Accounts receivable, net
    2,413,000       355,000  
Inventory, net
    3,415,000       5,278,000  
Prepaid expenses and other current assets
    442,000       416,000  
 
           
Total Current Assets
    10,209,000       13,618,000  
 
               
Property and equipment, net of accumulated depreciation of $19,129,000 and $19,943,000, respectively
    3,961,000       2,739,000  
Patents, licenses and purchased technology, net of accumulated amortization of $1,722,000 and $2,055,000, respectively
    2,236,000       2,252,000  
Investment in joint venture
          521,000  
Other assets
    219,000       228,000  
 
           
Total Assets
  $ 16,625,000     $ 19,358,000  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current Liabilities:
               
Accounts payable
  $ 1,467,000     $ 707,000  
Accrued expenses
    1,405,000       578,000  
Proceeds for shares to be issued
    4,000,000        
Current portion of capitalized lease obligations
    45,000       80,000  
 
           
Total Current Liabilities
    6,917,000       1,365,000  
 
               
Other long term liabilities
    518,000       441,000  
 
           
Total Liabilities
    7,435,000       1,806,000  
 
               
Commitments and contingencies (Notes 9, 10 and 11)
               
 
               
Stockholders’ Equity:
               
Preferred stock, $.001 par value, 2,000,000 shares authorized, zero and 611,523 issued and outstanding, respectively
          1,000  
Common stock, $.001 par value, 250,000,000 shares authorized, 12,511,414 and 17,869,030 shares issued and outstanding, respectively
    12,000       18,000  
Capital in excess of par value
    209,163,000       230,219,000  
Accumulated deficit
    (199,985,000 )     (212,686,000 )
 
           
Total Stockholders’ Equity
    9,190,000       17,552,000  
 
           
 
               
Total Liabilities and Stockholders’ Equity
  $ 16,625,000     $ 19,358,000  
 
           
See accompanying notes to the consolidated financial statements

F-2


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.
CONSOLIDATED STATEMENT OF OPERATIONS
                         
    Years Ended December 31,  
    2006     2007     2008  
Net revenues:
                       
Net commercial product revenues
  $ 17,697,000     $ 12,787,000     $ 6,768,000  
Government and other contract revenues
    3,361,000       5,115,000       4,525,000  
Sub license royalties
    20,000              
 
                 
Total net revenues
    21,078,000       17,902,000       11,293,000  
Costs and expenses:
                       
Cost of commercial product revenues
    15,922,000       12,944,000       8,911,000  
Contract research and development
    2,407,000       2,906,000       3,649,000  
Other research and development
    3,488,000       3,172,000       3,394,000  
Selling, general and administrative
    9,086,000       8,123,000       8,151,000  
Restructuring expenses and impairment charges
    38,000             141,000  
Write off Goodwill
    20,107,000              
 
                 
Total costs and expenses
    51,048,000       27,145,000       24,246,000  
 
                 
Loss from operations
    (29,970,000 )     (9,243,000 )     (12,953,000 )
Interest income
    391,000       156,000       284,000  
Interest expense
    (45,000 )     (39,000 )     (32,000 )
 
                 
Net loss
  $ (29,624,000 )   $ (9,126,000 )   $ (12,701,000 )
 
                 
 
                       
Basic and diluted net loss per common share
  $ (2.37 )   $ (0.73 )   $ (0.77 )
 
                 
 
                       
Basic and diluted weighted average number of common shares outstanding
    12,483,367       12,487,593       16,402,509  
 
                 
See accompanying notes to the consolidated financial statements

F-3


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
                                                                 
    Convertible Preferred                   Capital in   Receivable        
    Stock   Common Stock   Excess of   From   Accumulated    
    Shares   Amount   Shares   Amount   Par Value   Stockholder   Deficit   Total
     
Balance at December 31, 2005
                12,483,431     $ 12,000     $ 208,545,000     $ (65,000 )   $ (161,235,000 )   $ 47,257,000  
Issuance of common stock and warrants
                    (64 )                                        
Issuance of options
                                    280,000                       280,000  
Reserve for impairment
                                            38,000               38,000  
Net loss
                                                    (29,624,000 )     (29,624,000 )
Balance at December 31, 2006
                12,483,367       12,000       208,825,000       (27,000 )     (190,859,000 )     17,951,000  
     
Exercise of stock options
                    3,350               26,000                       26,000  
Issuance of common stock
                                    (27,000 )                     (27,000 )
Issuance of options and warrants
                    24,697               339,000                       339,000  
Reserve for impairment
                                            27,000               27,000  
Net loss
                                                    (9,126,000 )     (9,126,000 )
     
Balance at December 31, 2007
                12,511,414     $ 12,000     $ 209,163,000     $     $ (199,985,000 )   $ 9,190,000  
Exercise of stock options
                                                               
Issuance of common stock
                    5,101,361       5,000       10,563,000                       10,568,000  
Issuance of options/awards and warrants
                    256,255       1,000       593,000                       594,000  
Issuance of Series A Preferred
    611,523       1,000                       9,900,000                       9,901,000  
Net loss
                                                    (12,701,000 )     (12,701,000 )
     
Balance at December 31, 2008
    611,523     $ 1,000       17,869,030     $ 18,000     $ 230,219,000     $     $ (212,686,000 )   $ 17,552,000  
     
See accompanying notes to the consolidated financial statements.

F-4


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
                         
    Years Ended December 31,  
    2006     2007     2008  
CASH FLOWS FROM OPERATING ACTIVITIES:
                       
 
Net loss
  $ (29,624,000 )   $ (9,126,000 )   $ (12,701,000 )
Adjustments to reconcile net loss to net cash used for operating activities:
                       
Depreciation and amortization
    2,600,000       2,333,000       1,735,000  
Warrants and options charges
    280,000       339,000       587,000  
Provision for excess and obsolete inventories
    360,000       160,000       17,000  
Reserve for impairment of note and interest receivable from stockholder
    38,000       (583,000 )      
Write off Goodwill
    20,107,000              
Changes in assets and liabilities:
                       
Accounts receivable
    631,000       (877,000 )     2,057,000  
Inventory
    (974,000 )     2,403,000       (1,880,000 )
Prepaid expenses and other current assets
    115,000       574,000       (26,000 )
Patents and licenses
    (217,000 )     (169,000 )     (315,000 )
Other assets
    128,000       16,000       9,000  
Accounts payable and accrued expenses
    (727,000 )     (465,000 )     (1,603,000 )
 
                 
Net cash used in operating activities
    (7,283,000 )     (5,395,000 )     (12,120,000 )
 
                       
CASH FLOWS FROM INVESTING ACTIVITIES:
                       
 
Proceeds from the sale of property and equipment
          26,000        
Purchase of property and equipment
    (229,000 )     (191,000 )     (179,000 )
Investment in joint venture
                (521,000 )
 
                 
Net cash used in investing activities
    (229,000 )     (165,000 )     (700,000 )
 
                       
CASH FLOWS FROM FINANCING ACTIVITIES:
                       
 
                       
Proceeds from shares to be issued
          4,000,000        
Payments on long-term obligations
    (19,000 )     (14,000 )      
Gross proceeds from sale of common stock and exercise of warrants and options
          26,000       16,450,000  
 
                 
Net cash provided by (used in) financing activities
    (19,000 )     4,012,000       16,450,000  
 
                 
Net increase (decrease) in cash and cash equivalents
    (7,531,000 )     (1,548,000 )     3,630,000  
Cash and cash equivalents at beginning of year
    13,018,000       5,487,000       3,939,000  
 
                 
Cash and cash equivalents at end of year
  $ 5,487,000     $ 3,939,000     $ 7,569,000  
 
                 
See accompanying notes to the consolidated financial statements.

F-5


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 — The Company
     Superconductor Technologies Inc. (together with our subsidiaries, “we” or “us”) was incorporated in Delaware on May 11, 1987 and maintains its headquarters in Santa Barbara, California. We operate in a single industry segment, the research, development, manufacture and marketing of high-performance infrastructure products for wireless voice and data applications. Our current commercial products are divided into three product offerings: SuperLink (high-temperature superconducting filters), AmpLink (high performance, ground-mounted amplifiers) and SuperPlex (high performance multiplexers). Our research and development contracts are used as a source of funds for our commercial technology development. From 1987 to 1997, we were engaged primarily in research and development and generated revenues primarily from government research contracts.
     We continue to be involved as either contractor or subcontractor on a number of contracts with the United States government. These contracts have been and continue to provide a significant source of revenues for us. For 2006, 2007 and 2008, government related contracts account for 16%, 29%, and 40%, respectively, of our net revenues.
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
     In 2008, we incurred a net loss of $12.7 million and had negative cash flows from operations of $12.1 million. In 2007, we incurred a net loss of $9.1 million and had negative cash flows from operations of $5.4 million.
     At December 31, 2008 we had $7.6 million in cash. Our cash resources, together with our line of credit, and a planned inventory reduction, may not be sufficient to fund our business through 2009. We believe one of the key factors to our liquidity will be our ability to successfully execute on our plans to increase sales levels in a highly concentrated industry where we experience significant fluctuations in sales from quarter to quarter. Our cash requirements will also depend on numerous other variable factors, including the rate of growth of sales, the timing and levels of products purchased, payment terms and credit limits from manufacturers, and the timing and level of accounts receivable collections. Because of the uncertainty of these many factors, we may need to raise funds in the next six months to meet our working capital needs.
     We cannot assure you that additional financing will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.
Principles of Consolidation
     The consolidated financial statements include the accounts of Superconductor Technologies Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated from the consolidated financial statements.
Cash and Cash Equivalents
     Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with quality financial institutions and from time to time exceed FDIC limits. Historically, we have not experienced any losses due to such concentration of credit risk.
Accounts Receivable
     We sell predominantly to entities in the wireless communications industry and to entities of the United States government. We grant uncollateralized credit to our customers. We perform usual and customary credit evaluations of our customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine

F-6


Table of Contents

the allowance based on historical write-off experience. Past due balances are reviewed for collectibility. Accounts balances are charged off against the allowance when we deem it is probable the receivable will not be recovered. We do not have any off balance sheet credit exposure related to our customers.
Revenue Recognition
     Commercial revenues are principally derived from the sale of our SuperLink, AmpLink and SuperPlex family of products and are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) customer’s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.
     Contract revenues are principally generated under research and development contracts. Contract revenues are recognized utilizing the percentage-of-completion method measured by the relationship of costs incurred to total estimated contract costs. If the current contract estimate were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for the total anticipated loss. Revenues from research related activities are derived primarily from contracts with agencies of the United States Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. These contracts include cost-plus, fixed price and cost sharing arrangements and are generally short-term in nature.
     All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Contract audits through 2003 are closed. Based on historical experience and review of current projects in process, we believe that the audits will not have a significant effect on our financial position, results of operations or cash flows.
Shipping and Handling Fees and Costs
     Shipping and handling fees billed to customers are included in net commercial product revenues. Shipping and handling fees associated with freight are generally included in cost of commercial product revenues.
Warranties
     We offer warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with our customers. Such warranties require us to repair or replace defective product returned to us during such warranty period at no cost to the customer. Our estimate for warranty related costs is recorded at the time of sale based on our actual historical product return rates and expected repair costs. Such costs have been within our expectations.
Guarantees
     In connection with the sales and manufacturing of our commercial products, we indemnify, without limit or term, our customers and contract manufacturers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our guarantee because of the uncertainty as to whether a claim might arise and how much it might total. Historically, we have not incurred any expenses related to these guarantees.
Research and Development Costs
     Research and development costs are expensed as incurred and include salary, facility, depreciation and material expenses. Research and development costs incurred solely in connection with research and development contracts are charged to contract research and development expense. Other research and development costs are charged to other research and development expense.
Inventories
     Inventories are stated at the lower of cost or market, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase

F-7


Table of Contents

commitments. If the results of the review determine that a write-down is necessary, we recognize a loss in the period in which the loss is identified, whether or not the inventory is retained. Our inventory reserves establish a new cost basis for inventory and are not reversed until we sell or dispose of the related inventory. Such provisions are established based on historical usage, adjusted for known changes in demands for such products, or the estimated forecast of product demand and production requirements. Costs associated with idle capacity are expensed immediately.
Property and Equipment
     Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to five years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded in selling, general and administration expenses. In 2008, we disposed of older, fully depreciated equipment with an acquisition cost of $598,000. There was no gain or loss on said disposition.
Patents, Licenses and Purchased Technology
     Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or approximately seventeen years. Purchased technology acquired through the acquisition of Conductus, Inc. in 2002 was recorded at its estimated fair value and is amortized using the straight-line method over seven years.
Goodwill
     Goodwill represents the excess of purchase price over fair value of net assets acquired in connection with the acquisition of Conductus in 2002. Conductus was acquired primarily for the synergies the acquisition would bring to our existing business of developing, manufacturing and marketing products for the commercial wireless telecommunications business and for the synergies it would have on our fund raising abilities.
     At July 2006, our market capitalization had declined to $25.5 million, an amount less than our total book value. We concluded that our declining stock price constituted an event under FAS 142 and required us to test for goodwill impairment as of July 2006. Our analysis led us to reasonably estimate at that time that our fair market value was less than our net assets excluding goodwill. Accordingly, we recorded a full write-down of the goodwill ($20.1 million) in the second quarter 2006.
Long-Lived Assets
     The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in the business are written off in the period identified since they will no longer generate any positive cash flows for us. Periodically, long lived assets that will continue to be used by us will need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We tested our long lived assets for recoverability during fiscal 2008 and determined there was no impairment.
Restructuring Expenses
     Liability for costs associated with an exit or disposal activity are recognized when the liability is incurred.
Loss Contingencies
     In the normal course of our business we are subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. The costs of our defense in such matters are expensed as incurred. Insurance proceeds recoverable are recorded when deemed probable.

F-8


Table of Contents

Income Taxes
     The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 109, Accounting for Income Taxes, which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.
     In July 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation (“FIN”) No. 48, Accounting for Uncertainty in Income Taxes — An Interpretation of FASB Statement No. 109 (“FIN 48”). FIN 48 clarifies the accounting for uncertainty in income taxes and sets a consistent framework to determine the appropriate level of tax reserve to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized. FIN 48 also sets out disclosure requirements to enhance transparency of our tax reserves. We adopted FIN 48 effective January 1, 2007, and the provisions of FIN 48 have been applied to all income tax positions commencing from that date. There was no material impact from this adoption. As of December 31, 2008, we had net operating loss carryforwards for federal and state income tax purposes of approximately $291.4 million and $168.8 million, respectively. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying balance sheet.
Marketing Costs
     All costs related to marketing and advertising our products are expensed as incurred or at the time the advertising takes place. Advertising costs were not material in each of the three years in the period ended December 31, 2008.
Net Loss Per Share
     Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each year. Potential common shares are not included in the calculation of diluted loss per share because their effect is anti-dilutive.
Stock-based Compensation
     Effective January 1, 2006, we adopted the provisions of SFAS No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123(R)”). Compensation cost under SFAS No. 123(R) is recognized ratably using the straight-line attribution method over the expected vesting period. Prior periods are not restated under this transition method.
     The following table presents details of total stock-based compensation expense that is included in each functional line item on our consolidated statements of income:
                         
    2006     2007     2008  
Cost of revenue
    6,000       14,000       22,000  
Research and development
    23,000       56,000       122,000  
Selling, general and administrative
    251,000       269,000       443,000  
 
                 
Total stock-based compensation expense
  $ 280,000     $ 339,000     $ 587,000  
 
                 
     The impact to the Consolidated Statement of Operations for 2008, 2007 and 2006 on basic and diluted earnings per share was $0.04, $0.03 and $0.02, respectively. No stock compensation cost was capitalized during the periods.
Use of Estimates

F-9


Table of Contents

     The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the financial statements relate to the assessment of the carrying amount of accounts receivable, inventory, fixed assets, intangibles, goodwill, estimated provisions for warranty costs, accruals for restructuring and lease abandonment costs, contract revenues, income taxes and disclosures related to the litigation. Actual results could differ from those estimates and such differences may be material to the financial statements.
Fair Value of Financial Instruments
     The carrying amount of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to the short-term nature of these instruments. We estimate that the carrying amount of the debt approximates fair value based on our current incremental borrowing rates for similar types of borrowing arrangements.
Comprehensive Income
     We have no items of other comprehensive income in any period and consequently do not report comprehensive income.
Segment Information
     We operate in a single business segment, the research, development, manufacture and marketing of high performance products used in cellular base stations to maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Net commercial product revenues are primarily derived from the sales of our SuperLink, AmpLink and SuperPlex products. We currently sell most of our products directly to wireless network operators in the United States. Net revenues derived principally from government research and development contracts are presented separately on the statement of operations for all periods presented.
Reverse Stock Split
     On March 13, 2006, we made a one-for-ten (1:10) reverse stock split effective as of the open of business. All results prior to that time have been adjusted to reflect the impact of that split.
Certain Risks and Uncertainties
     Our long-term prospects are dependent upon the continued and increased market acceptance for our products.
     We currently sell most of our products directly to wireless network operators in the United States and our product sales have historically been concentrated in a small number of customers. In 2008, we had two customers that represented 44% and 13% of total net revenues. At December 31, 2007, these two customers represented 26% and 15% of accounts receivable. In 2006, we had three customers that represented 44%, 20% and 16% of total net revenues. The loss of or reduction in sales, or the inability to collect outstanding accounts receivable, from any of these customers could have a material adverse effect on our business, financial condition, results of operations and cash flows.

F-10


Table of Contents

     We currently rely on one supplier for purchase of high quality substrates for growth of high-temperature superconductor films and on a limited number of suppliers for other key components of our products. The loss of any of these suppliers could have material adverse effect on our business, financial condition, results of operations and cash flows.
     In connection with the sales of our commercial products, we indemnify, without limit or term, our customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our guarantee because of the uncertainty as to whether a claim might arise and how much it might total.
     For more risks of our business, see Item 1A, “Risk Factors” in our Annual Report on Form 10-K and other filings with the Securities and Exchange Commission.
Recent Accounting Pronouncements
     In January 2009, the FASB issued FSP EITF 99-20-1, “Amendments to the Impairment Guidance of EITF Issue No. 99-20” (FSP EITF 99-20-1). FSP EITF 99-20-1 amends the impairment guidance in EITF Issue No. 99-20, “Recognition of Interest Income and Impairment on Purchased Beneficial Interests and Beneficial Interests That Continue to Be Held by a Transferor in Securitized Financial Assets”, to achieve more consistent determinations of whether an other-than-temporary impairment has occurred. FSP EITF 99-20-1 also retains and emphasizes the objective of an other-than-temporary impairment assessment and the related disclosure requirements in SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities”, and other related guidance. FSP EITF 99-20-1 is effective for interim and annual reporting periods ending after December 15, 2008, and shall be applied prospectively. Retrospective application to a prior interim or annual reporting period is not permitted. The implementation of this standard did not have a material impact on our consolidated financial statements.
     In December, 2008, the FASB issued FSP FAS 140-4 and FIN 46(R)-8, “Disclosures Related to Asset Transfers, and Interests in Variable Interest Entities ”, which requires public companies to provide disclosures similar to those proposed in the pending amendments to Statement 140 and Interpretation 46(R). The FSP requires additional disclosures about transfers of financial assets and an enterprise’s involvement with variable interest entities. These disclosures should help improve transparency in the current market environment. The FSP is effective for the first reporting period (interim or annual) that ends after December 15, 2008. The adoption of this position did not have a material effect on our consolidated financial statements.
     In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles (“SFAS No. 162”). SFAS No. 162 identifies the sources of accounting principles and the framework for selecting the principles used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles (the GAAP hierarchy). SFAS No. 162 will become effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. We do not expect the adoption of SFAS No. 162 to have a material effect on our consolidated results of operations and financial condition.
     In April 2008, the FASB issued FASB Staff Position No. 142-3 (“FSP No. 142-3”), Determination of the Useful Life of Intangible Assets. FSP No. 142-3 amends the factors an entity should consider in developing renewal or extension assumptions used in determining the useful life of recognized intangible assets under SFAS No. 142, Goodwill and Other Intangible Assets. This new guidance applies prospectively to intangible assets that are acquired individually or with a group of other assets in business combinations and asset acquisitions. FSP No. 142-3 is effective for financial statements issued for fiscal years and interim periods beginning after December 15, 2008. We are currently evaluating the effect that the adoption of FSP No. 142-3 will have on our consolidated results of operations and financial condition.
     In February 2008, the FASB issued FSP 157-2 “Partial Deferral of the Effective Date of Statement 157” (FSP 157-2). FSP 157-2 delays the effective date of SFAS No. 157, for all non-financial assets and non-financial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually) to fiscal years beginning after November 15, 2008. We are currently assessing the impact of SFAS No. 157 for non-financial assets and non-financial liabilities on our consolidated financial position and results of operations. We do not expect that the implementation of this standard, for financial assets and financial liabilities, will have a material impact on our consolidated financial position or results of operations.

F-11


Table of Contents

Note 3-Short Term Borrowings
     We have a line of credit with a bank. The line of credit expires July 2009 and is structured as a sale of accounts receivable. The agreement provides for the sale of up to $5 million of eligible accounts receivable, with advances to us totaling 80% of the receivables sold. Advances under the agreement are collateralized by all of our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions.
     Advances bear interest at the prime rate (3.25% at December 31, 2008) plus 2.50% subject to a minimum monthly charge. There was no amount outstanding under this borrowing facility at December 31, 2008.
     The agreement contains representations and warranties, affirmative and negative covenants and events of default customary for financings of this type. The failure to comply with these provisions, or the occurrence of any one of the events of default, would prevent any further borrowings and would generally require the repayment of any outstanding borrowings. Such representations, warranties and events of default include (a) non-payment of debt and interest hereunder, (b) non-compliance with terms of the agreement covenants, (c) insolvency or bankruptcy, (d) material adverse change, (e) merger or consolidation where our shareholders do not hold a majority of the voting rights of the surviving entity, (f) transactions outside the normal course of business, or (g) payment of dividends.
Note 4 — Notes Receivable From Stockholder
     A former director and stockholder executed two notes aggregating $820,244 in principal amount in connection with the exercise in December 2000 of two options. Through the third quarter of, 2005, we carried the principal (as “Notes Receivable from Stockholder”) and accrued interest (as “Prepaid Expenses and Other Current Assets”) for both notes as assets on our balance sheet. In December 2005, we filed a lawsuit to collect both notes and recorded a reserve for the value of the notes (principal plus accrued interest) in excess of the market value of the collateral securing the notes. In 2007, we received $610,000 in full satisfaction of our claims including interest and attorneys’ fees, and then rescinded the second purported option exercise and canceled the related note.
Note 5 — Income Taxes
     We incurred a net loss in each year of operation since inception resulting in no current or deferred tax expense for 2006, 2007 and 2008.
     The benefit for income taxes differs from the amount obtained by applying the federal statutory income tax rate to loss before benefit for income taxes for 2006, 2007 and 2008 as follows:
                         
    2006   2007   2008
Tax benefit computed at Federal statutory rate
    34.0 %     34.0 %     34.0 %
Increase (decrease) in taxes due to:
                       
Change in valuation allowance
    (16.7 )     (39.8 )     (39.8 )
State taxes, net of federal benefit
    5.8       5.8       5.8  
Impairment of Goodwill (not deductible for tax)
    (23.1 )            
     
 
    %     %     %
     
     The significant components of deferred tax assets (liabilities) at December 31 are as follows:
                 
    2007   2008
Loss carryforwards
  $ 105,460,000     $ 108,940,000  
Capitalized research and development
    2,710,000       1,468,000  
Depreciation
    2,582,000       2,541,000  
Tax credits
    3,822,000       3,916,000  
Inventory
    415,000       343,000  
Purchase accounting adjustments
    46,000        
Acquired intellectual property
    (190,000 )     (90,000 )
Other
    437,000       540,000  
Less: valuation allowance
    (115,282,000 )     (117,658,000 )
     
 
  $     $  
     
     The valuation allowance increased by $2,376,000 in 2008, $3,129,000 in 2007 and $5,854,000 in 2006.

F-12


Table of Contents

     As of December 31, 2008, we had net operating loss carryforwards for federal and state income tax purposes of approximately $291.4 million and $168.8 million, respectively, which expire in the years 2009 through 2028. Of these amounts $88.3 million and $23.5 million, respectively, resulted from the acquisition of Conductus. Included in the net operating loss carryforwards are deductions related to stock options of approximately $24.1 million and $13.1 million for federal and California income tax purposes, respectively. To the extent net operating loss carryforwards are recognized for accounting purposes the resulting benefits related to the stock options will be credited to stockholders’ equity. In addition, we had research and development and other tax credits for federal and state income tax purposes of approximately $3.0 million and $1.4 million, respectively, which expire in the years 2009 through 2028. Of these amounts $661,000 and $736,000, respectively resulted from the acquisition of Conductus.
     Due to the uncertainty surrounding their realization, we have recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying balance sheet.
     Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return (usually the “applicable federal funds rate”, as defined in the Internal Revenue Code) and the value of the corporation at the time of a “change of ownership” as defined by Section 382. We had changes in ownership in August 1999 and December 2002. In addition, we acquired the right to Conductus’ net operating losses, which are also subject to the limitations imposed by Section 382. Conductus underwent three ownership changes, which occurred in February 1999, February 2001and December 2002. Therefore, the ability to utilize our net operating loss carryforwards of $94.3 million incurred prior to the ownership changes and Conductus’ net operating loss carryforwards of $83.7 million incurred prior to the ownership changes will be subject in future periods to an annual limitation of $1.3 million and $700,000, respectively. Net operating losses incurred by us subsequent to the ownership changes totaled $113.4 million and are not subject to this limitation.
Note 6 — Stockholders’ Equity
Preferred Stock
     Pursuant to our Certificate of Incorporation, the Board of Directors is authorized to issue up to 2,000,000 shares of preferred stock (par value $.001 per share) in one or more series and to fix the rights, preferences, privileges, and restrictions, including the dividend rights, conversion rights, voting rights, redemption price or prices, liquidation preferences, and the number of shares constituting any series or the designation of such series. In February 2008, we issued to BAOLI and two related purchasers a total of (a) 3,101,361 shares of our common stock and (b) 611,523 shares of our Series A Preferred Stock (convertible into 6,115,230 shares of our common stock) in exchange for net proceeds of $14.9 million in cash after offering costs of $89,000, of which $4.0 million had been received in 2007. Subject to the terms and conditions of our Series A Preferred Stock and to customary adjustments to the conversion rate, each share of our Series A Preferred Stock is convertible into ten shares of our common stock so long as the number of shares of our common stock beneficially owned by BAOLI and affiliates following such conversion does not exceed 9.9% of our outstanding common stock. Except for a preference on liquidation of $.01 per share, each share of Series A Preferred Stock is the economic equivalent of the ten shares of common stock into which it is convertible. In accordance with EITF issue No. 98-5, “Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios” and EITF Issue No. 00-27, “Application of Issue No. 98-5 to Certain Convertible Securities”, there is no beneficial conversion feature related to the conversion of the preferred shares, as the value of the common shares into which the preferred shares convert does not exceed the recorded amount of the preferred at date of issuance. Except as required by law, the Series A Preferred Stock does not have any voting rights.

F-13


Table of Contents

Common Stock
     In a registered direct offering completed in May 2008 we raised net proceeds of $5.6 million, net of offering costs of $442,000, from the sale of 2,000,000 shares of common stock at $3.00 per share based on a negotiated discount to market. We determined the offering price based principally on negotiations between us, the placement agent and the selected institutional investors and on our consideration of the closing prices (including high, low and average prices) and trading volumes of our common stock on the Nasdaq Capital Market primarily during the 30 trading days proceeding the date we determined the offering price.
     As noted above, in February 2008, we issued to BAOLI and two related purchasers a total of (a) 3,101,361 shares of our common stock and (b) 611,523 shares of our Series A Preferred Stock (convertible into 6,115,230 shares of our common stock) in exchange for net proceeds of $14.9 million in cash after offering costs of $89,000.
     Other than the $4 million cash deposit on the BAOLI stock sale described above, we raised no money from the sale of our common stock in 2007 or 2006.
Equity Awards
     We have five equity award option plans, the 1992 Stock Option Plan, the nonstatutory 1992 Directors Stock Option Plan, 1998 and 1999 Stock Option Plans and the 2003 Equity Incentive Plan (collectively, the “Stock Option Plans”) although we can only grant new options under the 2003 Equity Incentive Plan. Under the 2003 Equity Incentive Plan, stock awards may be made to our directors, key employees, consultants, and non-employee directors and may consist of stock options, stock appreciation rights, restricted stock awards, performance awards, and performance share awards. Stock options must be granted at prices no less than the market value on the date of grant.
     At December 31, 2008, 1,066,019 shares of common stock were available for future grants under the 2003 Equity Incentive Plan.
There were no stock option exercises in 2008 or 2006; 3,350 shares were issued on option exercises in 2007.
     For 2006, 2007 and 2008, the weighted average fair value of options has been estimated at the date of the grant using the Black-Scholes option-pricing model. The following are the significant weighted average assumptions used for estimating the fair value under our stock option plans:
                         
    2006   2007   2008
Per share fair value at grant date
  $ 2.55     $ 2.15     $ 3.57  
Risk free interest rate
    4.82 %     4.34 %     2.47 %
Expected volatility
    95 %     98 %     109 %
Dividend yield
    0 %     0 %     0 %
Expected life in years
    4.0       4.0       4.0  
     The expected life was based on the contractual term of the options and the expected employee exercise behavior. Typically, options to our employees have a 3 or 4 year vesting term and a 10 year contractual term. Options vest at 33% or 25%, respectively, after one year and thereafter vest ratably on a monthly basis. Options to Board Members have a 10 year contractual term and vest 50% after one year and 50% after two years. The risk-free interest rate is based on the U. S. Treasury zero-coupon issues with a remaining term equal to the expected option life assumed at the grant date. The future volatility is based on our 4 year historical volatility. We used an expected dividend yield of 0% because we have never paid a dividend and do not anticipate paying dividends. We assumed a 10% forfeiture rate based on historical stock option cancellation rates over the last 4 years.
     The impact of the stock options to the Consolidated Statement of Operations for 2008, 2007 and 2006 on net income was an expense of $453,000, $115,000 and $187,000 and $0.03, $0.01 and $0.01, respectively, on both basic and diluted earnings per share. No stock compensation cost was capitalized during the periods. The total compensation cost related to non-vested awards not yet recognized is $1.6 million and the weighted-average period over which the cost is expected to be recognized is 3.1 years.

F-14


Table of Contents

     At December 31, 2008, 1,066,019 shares of common stock were available for future grants and options covering 1,234,025 shares were outstanding but not yet exercised. Option activity during the three years ended December 31, 2008 was as follows:
                 
            Weighted
    Number of   Average
    Shares   Exercise Price
 
Outstanding at December 31, 2005
    1,202,376     $ 40.38  
Granted
    80,900       3.70  
Canceled
    (128,335 )     34.64  
Exercised
           
 
Outstanding at December 31, 2006
    1,154,941       38.33  
Granted
    45,670       2.96  
Canceled
    (455,403 )     41.68  
Exercised
    (3,350 )     7.42  
 
Outstanding at December 31, 2007
    741,858       34.24  
Granted
    576,590       4.83  
Canceled
    (84,423 )     9.60  
Exercised
           
 
Outstanding at December 31, 2008
    1,234,025     $ 22.18  
 
The following table summarizes information concerning currently outstanding and exercisable stock options at December 31, 2008:
                                         
                            Exercisable
            Weighted Average   Weighted           Weighted
Range of   Number   Remaining   Average   Number   Average
Exercise Prices   Outstanding   Contractual Life   Exercise Price   Exercisable   Exercise Price
$1.43 - $4.90
    205,600       8.58     $ 3.67       56,992     $ 3.54  
$5.12 - $5.80
    412,927       9.13     $ 5.12       2,200     $ 5.31  
$6.10 - $6.90
    236,500       6.40     $ 6.89       236,500     $ 6.89  
$7.02 - $39.38
    209,077       3.44     $ 19.87       208,448     $ 19.90  
$40.00 - $493.75
    169,921       1.70     $ 110.20       169,921     $ 110.20  
 
 
    1,234,025       6.53     $ 22.18       674,061     $ 36.67  
 
                                       
     Our outstanding options expire on various dates through July 2018. The weighted-average contractual term of stock options currently exercisable is slightly less than 4.4 years. At December 31, 2008, no outstanding stock options and no exercisable options had an exercise price less than the current market value or had any intrinsic value. The number of options exercisable and weighted average exercise price at December 31, 2007 and 2006 totaled 663,174 and $37.87 and 1,067,296 and $41.13, respectively.
     In July 2006, we issued restricted stock awards totaling 331,000 shares with a cliff vest after two years of service and a per share weighted average grant-date fair value of $1.50. A 10% forfeiture rate was assumed. In July 2008, 302,000 of these shares fully vested in one single installment and have been expensed over the prior periods as compensation expense. We issued 256,255 of these shares and withheld 45,745 shares for statutory minimum tax withholding requirements.
     In September 2008, we issued restricted stock awards totaling 20,000 shares with a cliff vest after two years of service and a per share weighted average grant-date fair value of $1.62. A 10% forfeiture rate was assumed.
     The impact to the Consolidated Statement of Operations for 2008 on net income was an expense of $134,000 and $0.01 on basic and diluted earnings per share. The 2007 and 2006 impact on net income was an expense of $223,000 and $93,000 and $0.02 and $0.01 on basic and diluted earnings per share, respectively. No stock compensation cost was capitalized during the periods. The total compensation cost related to non-vested awards not yet recognized is $25,000, and the weighted-average period over which the cost is expected to be recognized is 1.7 years.
Warrants

F-15


Table of Contents

     The following is a summary of outstanding warrants at December 31, 2008:
                                 
    Common Shares  
            Currently     Price per        
    Total     Exercisable     Share     Expiration Date  
 
Warrants related to August 2005 financing
    342,466       342,466     $ 6.74     August 16, 2010* **
Warrants related to April 2004 financing
    10,000       10,000       18.50     April 28, 2011*
 
                               
Total
    352,466       352,466                  
 
                           
 
*   The terms of these warrants contain net exercise provisions, under which holders can elect to receive common stock equal to the difference between the exercise price and the sale price for common shares on the exercise date or the date immediately preceding the exercise date instead of paying the exercise price in cash.
 
**   These warrants contain special anti-dilution adjustment provisions relating to the price of other issuances. Under the issuances in 2008, the exercise price of these warrants was adjusted to $6.74.
     No warrants were exercised during 2008 and 2006. During 2007, the BAOLI offering caused the exercise price and the number of shares of certain warrants issued in 2004 to be adjusted to $8.34 and 110,880, respectively. In November 2007, the holder of these warrants elected the net exercise provision of this warrant, and received 24,697 shares of our common stock.
Note 7 — Employee Savings Plan
     In December 1989, the Board of Directors approved a 401(k) savings plan (the “401(k) Plan”) for our employees that became effective in 1990. Eligible employees may elect to make contributions under the terms of the 401(k) Plan; however, contributions by us are made at the discretion of management. We contributed $287,000 to the 401(k) Plan in 2008 and we made no contributions to the 401(k) Plan in 2006 or 2007.
Note 8 — Commitments and Contingencies
Operating Leases
     We lease our offices and production facilities under a non-cancelable operating lease that expires in four years. This lease contains a minimum rent escalation clause that requires additional rental amounts after the first year. Rent expense for this lease with minimum annual rent escalation is recognized on a straight line basis over the minimum lease term. This lease also requires us to pay utilities, insurance, taxes and other operating expenses and contains one five-year renewal option at 95% of the then current market rental value.
     For 2006, 2007 and 2008, rent expense was $1,152,000, $1,104,000 and $1,122,000, respectively.
Capital Leases
     We leased certain property and equipment under a capital lease arrangement that expired in 2007.
Patents and Licenses
     We have entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. In the event that we fail to pay minimum annual royalties, these licenses may automatically be terminated. These royalty obligations terminate in 2009 to 2020. Royalty expenses totaled $156,000 in 2006, $172,000 in 2007 and $150,000 in 2008. Under the terms of certain royalty agreements, royalty payments made may be subject to audit. There have been no audits to date and we do not expect any possible future audit adjustments to be significant.

F-16


Table of Contents

The minimum lease payments under operating and capital leases and license obligations are as follows:
                 
            Operating  
Years Ended December 31,   Licenses     Leases  
 
               
2009
  $ 150,000     $ 1,480,000  
2010
    150,000       1,531,000  
2011
    150,000       1,442,000  
2012
    150,000       9,000  
2013
    150,000       1,000  
Thereafter
    900,000        
 
           
 
               
Total payments
  $ 1,650,000     $ 4,463,000  
 
           
Note 9 — Contractual Guarantees and Indemnities
     During our normal course of business, we make certain contractual guarantees and indemnities pursuant to which we may be required to make future payments under specific circumstances. We have not recorded any liability for these contractual guarantees and indemnities in the accompanying consolidated financial statements.
Warranties
     We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods.
Intellectual Property Indemnities
     We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.
Director and Officer Indemnities and Contractual Guarantees
     We have entered into indemnification agreements with our directors and executive officers, which require us to indemnify such individuals to the fullest extent permitted by Delaware law. Our indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnifications may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed against a director or executive officer, we are unable to determine the maximum amount of losses that we could incur relating to such indemnifications. Historically, any amounts payable pursuant to such director and officer indemnifications have not had a material negative effect on our business, financial condition or results of operations.
     We have also entered into severance and change in control agreements with certain of our executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with us.
General Contractual Indemnities/Products Liability
     During the normal course of business, we enter into contracts with customers where we agreed to indemnify the other party for personal injury or property damage caused by our products. Our indemnification obligations under such agreements are not generally limited in amount or duration. Given that the amount of any potential liabilities related to such indemnities

F-17


Table of Contents

cannot be determined until a lawsuit has been filed against a director or executive officer, we are unable to determine the maximum amount of losses that we could incur relating to such indemnifications. Historically, any amounts payable pursuant to such guarantees have not had a material negative effect our business, financial condition or results of operations. We maintain general and product liability insurance as well as errors and omissions insurance, which may provide a source of recovery to us in the event of an indemnification claim.
Short Term Borrowings
     We have a line of credit with a bank. The line of credit expires July 2009 and is structured as a sale of accounts receivable. The agreement provides for the sale of up to $5 million of eligible accounts receivable, with advances to us totaling 80% of the receivables sold. Advances under the agreement (See Note 3) are collateralized by all our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions. Under the terms of the agreement, if the bank determines that there is a material adverse change in our business, they can exercise all their rights and remedies under the agreement, including demanding immediate payment of outstanding amounts. There was no amount outstanding under this facility at December 31, 2008
Contractual Contingency
     We have a contract to deliver several custom products to a government contractor, with respect to which delivery of the product was delayed because we were unable to manufacture the products for technical reasons. In December 2008, new terms and amended specifications were agreed upon, and we now expect to deliver these custom products in July 2009.
Note 10-Legal Proceedings
Settlement of Litigation
     In March 2007, we entered into a Settlement Agreement and Mutual Release of All Claims with a former director and stockholder to settle a lawsuit to collect amounts due under two notes, under which we received a payment of $610,000 in April 2007 in payment of one note, including interest and attorneys’ fees, and the rescission of the second related note.
Routine Litigation
     We may be involved in routine litigation arising in the ordinary course of our business, and, while the results of the proceedings cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our financial position, operating results or cash flows.
Note 11- Earnings Per Share
     We present “basic” and “diluted” earnings per common share pursuant to the provisions of SFAS No. 128, “Earnings per Share.” Basic earnings (loss) per share is based on the weighted-average number of common shares outstanding and diluted earnings (loss) per share is based on the weighted-average number of common shares outstanding plus all potentially dilutive common shares outstanding.
     Since their impact would be anti-dilutive, our loss per common share does not include the effect of the assumed exercise or vesting of any of the following shares:
                         
    2006     2007     2008  
 
                       
Outstanding stock options
    1,154,941       741,858       1,234,025  
Outstanding stock awards
    331,000       331,000       20,000  
Outstanding warrants
    828,838       468,745       352,466  
 
                 
Total
    2,314,779       1,541,603       1,606,491  
 
                 

F-18


Table of Contents

Note 12- Restructuring Expenses and Impairment Charges
     In the fourth quarter of 2008 we initiated an effort to reduce our cost structure and incurred $141,000 in severance related to this effort. The following summarizes the restructuring and impairment charges for 2006, 2007 and 2008:
                                                                         
    Years Ended December 31,  
    Restructuring     Impairment             Restructuring     Impairment             Restructuring     Impairment        
    Charges for     Charges for             Charges for     Charges for     Total for     Charges for     Charges for     Total for  
    2006     2006     Total for 2006     2007     2007     2007     2008     2008     2008  
Severance costs
  $     $     $     $     $     $     $ 141,000     $     $ 141,000  
Goodwill write-off
          20,107,000       20,107,000                                        
Impairment charge for notes receivable from shareholder and board member
          38,000       38,000                                      
 
                                                     
Total
          $ 20,145,000     $ 20,145,000                       $ 141,000           $ 141,000  
 
                                                     
Note 13— Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities
Balance Sheet Data:
                 
    December 31, 2007     December 31, 2008  
Accounts receivable:
               
Accounts receivable-trade
  $ 1,242,000     $ 110,000  
U.S. government accounts receivable-billed
    1,246,000       320,000  
Less: allowance for doubtful accounts
    (75,000 )     (75,000 )
 
           
 
  $ 2,413,000     $ 355,000  
 
           
                 
    December 31, 2007     December 31, 2008  
Inventories:
               
Raw materials
  $ 1,934,000     $ 2,753,000  
Work-in-process
    679,000       1,038,000  
Finished goods
    1,817,000       2,348,000  
Less: inventory reserves
    (1,015,000 )     (861,000 )
 
           
 
  $ 3,415,000     $ 5,278,000  
 
           
                 
    December 31, 2007     December 31, 2008  
Property and Equipment:
               
Equipment
  $ 15,951,000     $ 15,537,000  
Leasehold improvements
    6,732,000       6,741,000  
Furniture and fixtures
    407,000       404,000  
 
           
 
    23,090,000       22,682,000  
Less: accumulated depreciation and amortization
    (19,129,000 )     (19,943,000 )
 
           
 
  $ 3,961,000     $ 2,739,000  
 
           

F-19


Table of Contents

     Depreciation expense amounted to $2,277,000, $1,877,000 and $1,401,000 respectively, in 2006, 2007 and 2008. In 2007 and 2008, we disposed of older, fully depreciated equipment with an acquisition cost of $1,344,000 and $598,000, respectively. There were no gains or losses from these dispositions.
                 
    December 31, 2007     December 31, 2008  
Patents and Licenses:
               
Patents pending
  $ 705,000     $ 940,000  
Licenses pending
          39,000  
 
               
Patents issued
    983,000       1,059,000  
Less accumulated amortization
    (345,000 )     (409,000 )
 
           
Net patents issued
    638,000       650,000  
 
               
Licenses
    563,000       563,000  
Less accumulated amortization
    (134,000 )     (167,000 )
 
           
Net licenses Issued
    429,000       396,000  
 
               
Purchased technology
    1,706,000       1,706,000  
Less accumulated amortization
    (1,242,000 )     (1,479,000 )
 
           
Net purchased technology
    464,000       227,000  
 
           
 
  $ 2,236,000     $ 2,252,000  
 
           
     Amortization expense related to these items totaled $326,000, $331,000 and $334,000 respectively in 2006, 2007 and 2008. Amortization expenses related to these items are expected to total $331,000 in 2008 and 2009 and approximately $95,000 in 2010 and 2011.
                 
    December 31, 2007     December 31, 2008  
Accrued Expenses and Other Long Term Liabilities:
               
Salaries payable
  $ 307,000     $ 12,000  
Compensated absences
    371,000       375,000  
Compensation related
    369,000       12,000  
Warranty reserve
    380,000       261,000  
Deferred rent
    373,000       325,000  
Other
    123,000       114,000  
 
           
 
    1,923,000       1,099,000  
Less current portion
    (1,405,000 )     (658,000 )
 
           
Long term portion
  $ 518,000     $ 441,000  
 
           
                         
    2006     2007     2008  
Warranty Reserve Activity:
                       
Beginning balance
  $ 491,000     $ 428,000     $ 380,000  
Additions
    140,000       75,000       41,000  
Deductions
    (203,000 )     (123,000 )     (160,000 )
 
                 
Ending balance
  $ 428,000     $ 380,000     $ 261,000  
 
                 
 
                       
Lease Abandonment Costs:
                       
Beginning balance
  $ 225,000     $ 8,000        
Additions
                 

F-20


Table of Contents

                         
    2006     2007     2008  
Transfers from unfavorable lease costs
                 
Deductions
    (217,000 )     (8,000 )      
 
                 
Ending balance
  $ 8,000     $     $  
 
                 
 
                       
Product Line Exit Costs:
                       
Beginning balance
  $ 402,000     $ 319,000        
Additions
                 
Deductions
    (83,000 )     (319,000 )      
Change in estimate relating to previous exit costs accrual
                 
 
                 
Ending balance
  $ 319,000     $     $  
 
                 
 
                       
Severance Costs:
                       
Beginning balance
  $ 36,000     $ 32,000        
Additions
    218,000             141,000  
Deductions
    (222,000 )     (32,000 )      
 
                 
Ending balance
  $ 32,000     $     $ 141,000  
 
                 
Supplemental Cash Flow Information:
                         
    2006   2007   2008
 
                       
Cash paid for interest
  $ 45,000     $ 39,000     $ 32,000  
Note 14— Subsequent Event
Operating Lease
     In February 2009, we amended our office and production facilities lease. The base rent and the minimum annual escalation clause were reduced and the term of the lease was extended five years to November 2016.
Contract Funding
     In March 2009, the second phase of our U.S. Air Force contract was funded for an additional twelve months and provides for progress billing of up to $4.1 million.

F-21


Table of Contents

Quarterly Financial Data (Unaudited)
                                 
    First Quarter     Second Quarter     Third Quarter     Fourth Quarter  
 
                               
2008
                               
Net revenues (1)
  $ 3,471,000     $ 2,949,000     $ 3,595,000     $ 1,278,000  
Loss from operations (3)
    2,398,000       3,411,000       3,294,000       3,850,000  
Net loss
    2,308,000       3,349,000       3,235,000       3,809,000  
 
                               
Basic and diluted loss per common share
    (0.17 )     (0.21 )     (0.18 )     (0.21 )
Weighted average number of shares outstanding
    13,636,083       16,316,072       17,750,761       17,869,030  
 
                               
2007
                               
Net revenues (1)
  $ 4,183,000     $ 4,685,000     $ 4,121,000     $ 4,914,000  
Loss from operations (2)(3)
    (2,977,000 )     (2,006,000 )     (2,040,000 )     (2,220,000 )
Net loss
    (2,937,000 )     (1,982,000 )     (2,021,000 )     (2,187,000 )
 
                               
Basic and diluted loss per common share
  $ (0.24 )   $ (0.16 )   $ (0.16 )   $ (0.17 )
Weighted average number of shares outstanding
    12,483,367       12,483,367       12483,367       12,500,134  
 
(1)   Our revenues vary from quarter to quarter as our customers provide minimal lead-time prior to the release of their purchase orders and have non-binding commitments to purchase from us.
 
(2)   These quarters include sales of previously written-off inventory of $0, $138,000, $57,000 and $0, respectively.
 
(3)   Includes increased reserve for inventory obsolescence of $90,000, $70,000, $0 and $0, respectively, in the 2007 quarters and $0, $15,000, $0, and $2,000, respectively, in the 2008 quarters.

F-22


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.
Schedule II — Valuation and Qualifying Accounts
                                         
            Additions              
            Charge to     Charge to     Charge to        
    Beginning     Costs &     Other     Other     Ending  
    Balance     Expenses     Accounts     Deductions     Balance  
 
2008
                                       
Allowance for Uncollectible Accounts
  $ 75,000     $     $     $     $ 75,000  
Reserve for Inventory Obsolescence
    1,015,000       17,000             (171,000 )     861,000  
Reserve for Warranty
    380,000       41,000             (160,000 )     261,000  
Deferred Tax Asset Valuation Allowance
    115,282,000       2,376,000                   117,658,000  
 
                                       
2007
                                       
Allowance for Uncollectible Accounts
    75,000                         75,000  
Impairment for Notes Receivable from Stockholder
    1,007,000       (583,000 )           (424,000 )      
Reserve for Inventory Obsolescence
    1,367,000       (195,000 )           (157,000 )     1,015,000  
Reserve for Warranty
    428,000       75,000             (123,000 )     380,000  
Deferred Tax Asset Valuation Allowance
    112,153,000       3,129,000                   115,282,000  
 
                                       
2006
                                       
Allowance for Uncollectible Accounts
    75,000                         75,000  
Impairment for Notes Receivable from Stockholder
    969,000       38,000                   1,007,000  
Reserve for Inventory Obsolescence
            3,209,000       360,000       (2,202,000 )     1,367,000  
Reserve for Warranty
    491,000       140,000             (203,000 )     428,000  
Deferred Tax Asset Valuation Allowance
  $ 106,299,000     $ 5,854,000     $     $     $ 112,153,000  

F-23


Table of Contents

SIGNATURES
     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 20th day of March 2009.
         
  SUPERCONDUCTOR TECHNOLOGIES INC.
 
 
  By:   /s/ Jeffrey A. Quiram    
    Jeffrey A. Quiram   
    President and Chief Executive Officer   
 
POWER OF ATTORNEY
     KNOW ALL THESE PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints William J. Buchanan, his attorney-in-fact, with full power of substitution, for him in any and all capacities, to sign any and all amendments to this Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact or his substitute or substitutes, may do or cause to be done by virtue hereof.
     Pursuant to the requirements of the Securities Exchange Act of 1934, this Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
         
Signature   Title   Date
 
       
/s/ Jeffrey A. Quiram
 
Jeffrey A. Quiram
  President, Chief Executive Officer and  Director
(Principal Executive Officer)
  March 20, 2009
 
       
/s/ William J. Buchanan
 
William J. Buchanan
  Controller (Principal Accounting Officer) 
(Principal Financial Officer)
  March 20, 2009
 
       
/s/ David W. Vellequette
 
David W. Vellequette
  Director    March 20, 2009
 
       
/s/ Lynn J. Davis
 
Lynn J. Davis
  Director    March 20, 2009
 
       
/s/ Dennis J. Horowitz
 
Dennis J. Horowitz
  Director    March 20, 2009
 
       
/s/ Martin A. Kaplan
 
Martin A. Kaplan
  Director    March 20, 2009
 
       
/s/ John D. Lockton
 
John D. Lockton
  Chairman of the Board    March 20, 2009